Levitra for sale near me

Sorry, Joe Namath levitra for sale near me. Despite what you keep saying in those TV ads, under Medicare, seniors are not “entitled to eliminate copays and get dental care, dentures, eyeglasses, prescription drug coverage, in-home aides, unlimited transportation and home-delivered meals, all at no additional cost.” But if Democratic lawmakers in Congress have their say, seniors could soon be entitled to some of those services. Namath’s commercial is hawking private Medicare Advantage plans, which frequently do offer benefits traditional Medicare does not — in exchange for being limited levitra for sale near me to certain doctors and hospitals. €œTraditional” Medicare does not cover many benefits used overwhelmingly by its beneficiaries, including most vision, dental and hearing care, and drug coverage is available only by purchasing a separate insurance plan — Medicare Part D.

But Democrats in the House and Senate plan to try to change that as soon as this fall. On Monday, Senate Majority Leader Chuck Schumer released an outline of a coming budget bill that includes a directive to the Senate Finance Committee to expand Medicare “to include dental, levitra for sale near me vision, hearing benefits.” The catch — all the Democrats in the Senate and almost all in the House will have to agree on the entire budget bill for it to become law. Still, that raises a question about Medicare. Why has it taken so long to add such obviously needed benefits?.

As with almost everything to do with the levitra for sale near me U.S. Health system, the answer is complicated, and a combination of policy and politics. €œMedicare is the kind of program where you’d expect the benefits would be expanded over and over again. It’s popular, and benefits expansions poll well,” said Jonathan Oberlander, a levitra for sale near me professor of health policy at the University of North Carolina-Chapel Hill and author of the book “The Political Life of Medicare.” “It’s one of the great puzzles of Medicare politics.

Why benefit expansions have been so rare.” In fact, in the 56 years since Medicare became law, only a few benefits have been added to the package, which was created to emulate a 1965 Blue Cross/Blue Shield plan. During the 1980s and ’90s some preventive care levitra for sale near me was added, like pneumonia treatments and mammograms. Republicans spearheaded the addition of prescription drug coverage in 2003, when they controlled both Congress and the White House. But they decided to make that coverage separate from the program’s traditional benefit package.

Other efforts to expand levitra for sale near me benefits have not gone so well. In 1988, a bipartisan effort in Congress produced the Medicare Catastrophic Coverage Act, which would have added drug coverage to traditional Medicare and also would have plugged a hole. The fact that there is no limit on the amount patients can be charged for their share of covered services. That law, however, was repealed just a year later after seniors rebelled against being asked to foot most of the bill for the new benefits levitra for sale near me via a new income “surtax.” Today, Medicare beneficiaries still face the risk of unlimited expenses.

Medicare is funded by a combination of money paid directly to the government from paychecks and taxes paid by working Americans and their employers. That brings us to another big reason Medicare’s benefit package hasn’t been beefed up more — the cost of the current program. €œWhen Medicare levitra for sale near me was created, its architects assumed expansion, both in terms of population and in terms of benefits later,” said Oberlander. €œThey didn’t anticipate the shift in American politics to the right, and they didn’t anticipate that Medicare would be labeled a fiscal problem and that policymakers would be more concerned with avoiding the next trust fund shortfall than expanding benefits.” Indeed, in the ’80s and ’90s, Medicare spending was more often restrained than expanded.

A series of budget reconciliation bills trimmed levitra for sale near me millions of dollars out of Medicare — usually at the expense of payment to doctors, hospitals and other health providers. As the years wore on, Medicare has remained popular, but it has grown less generous than most private insurance policies. Many Medicare patients, however, have been able to find supplemental coverage to fill in what Medicare does not cover, through private “Medigap” policies, employer-provided retiree plans or Medicaid for those with low incomes. Increasingly popular in recent years have been those Medicare managed-care plans, now known as Medicare Advantage, that were first authorized in 1982 and often provide levitra for sale near me extra benefits for members.

All of that “has taken some of the pressure off” lawmakers to expand the program, Oberlander said. And a final reason that vision, hearing and dental care have not been added to standard Medicare is that they are far from the most critical gaps in Medicare’s benefit package. For example, Medicare does not cover levitra for sale near me long-term custodial care — the sort of non-nursing, personal care that provides assistance in activities of daily living such as bathing, dressing, eating, getting in or out of a bed or chair, using the bathroom or preparing food. Custodial care tends to be both very expensive ($50,000 to $100,000 a year or more) and needed by a large number of beneficiaries, particularly after age 80.

Efforts over the years to create a government long-term care benefit have been largely unsuccessful. A very limited program, the CLASS Act, was part of the Affordable Care Act in levitra for sale near me 2010 but was repealed before it could take effect because its financing was deemed insufficient. President Joe Biden has called for Congress to include billions of dollars for caregiving in the infrastructure package Democrats will work on this fall. Also, as previously mentioned, traditional Medicare includes no limits on patient cost sharing — the percentage or amount of a medical bill that a beneficiary levitra for sale near me must pay.

Its basic hospital benefit runs out after 90 days, and the 20% coinsurance (the percentage patients are responsible for) on outpatient care runs indefinitely. So why are dental, vision and hearing coverage on the front burner now as lawmakers consider beefing up the program?. Part may be self-serving for lawmakers tasked with levitra for sale near me appropriating funds. All three benefits “are less expensive than [adding] nursing home” coverage, said Oberlander.

But a big part is politics. On the campaign trail, Biden promised to lower Medicare’s eligibility levitra for sale near me age from 65 to 60. €œMedicare for All” advocates like Senate Budget Committee Chair Bernie Sanders (I-Vt.) pledged to try to do the same, and lowering the eligibility age is included in the outline Schumer shared with Senate Democrats as an option. But lowering the eligibility age is vehemently opposed by hospitals and other health providers, who fear they will lose money if people currently covered by higher-paying private insurance are covered by Medicare instead.

That makes benefits expansion the levitra for sale near me much easier choice for Congress. That is not saying it will happen. The Congressional Budget Office said the vision, hearing and dental benefits included in a bill passed by the House in 2019 would have cost levitra for sale near me an estimated $358 billion over 10 years. But this is the closest the benefits have gotten to enactment since Medicare’s inception.

HealthBent, a regular feature of Kaiser Health News, offers insight and analysis of policies and politics from KHN’s chief Washington correspondent, Julie Rovner, who has covered health care for more than 30 years. Julie levitra for sale near me Rovner. jrovner@kff.org, @jrovner Related Topics Contact Us Submit a Story TipThe Centers for Disease Control and Prevention’s recent guidance on students and masking “lacks a well-grounded scientific justification.” Florida Gov. Ron DeSantis in a July 30 executive order On July 30, Florida Gov.

Ron DeSantis issued an executive order stating that schools couldn’t mandate levitra for sale near me that their students wear masks, and that it should be up to parents to decide whether they want their children masked in school buildings. The order also said the state can deny funding to districts that don’t comply. One part of the order particularly caught our attention because of what it said about masks. €œWHEREAS, despite recent Centers for Disease Control and Prevention (CDC) ‘guidance,’ forcing levitra for sale near me students to wear masks lacks a well-grounded scientific justification.

Indeed, a Brown University study analyzed erectile dysfunction treatment data for schools in Florida and found no correlation with mask mandates.” The executive order came on the heels of the CDC guidelines for reopening K-12 schools, which recommended that everyone age 2 and up should wear masks whether they are vaccinated or not. This guidance was issued partly because of the increase in erectile dysfunction treatment cases due levitra for sale near me to the delta variant, which is more contagious than other versions of the levitra. It was also issued because erectile dysfunction treatments have not yet been authorized for use in children under age 12. During the levitra, DeSantis, a Republican, has consistently taken positions contrary to public health guidance from experts and said he wants Florida to remain open.

€œIn Florida, there will be no lockdowns, there will be no school closures, there will be no restrictions and no levitra for sale near me mandates,” DeSantis said during a speech introducing the executive order, which drew immediate pushback. President Joe Biden criticized his position and a group of Florida parents filed a lawsuit to block the order. But the state is currently considered a erectile dysfunction treatment hot spot. The Florida levitra for sale near me Department of Health reported there were 134,506 new cases of erectile dysfunction treatment from July 30 to Aug.

5. That’s compared to 11,837 new cases over the earlier week-long period beginning June 4, before the delta variant surge. Hospitalizations have levitra for sale near me also increased. Total erectile dysfunction treatment-related hospitalizations were at almost 14,000 on Aug.

9, compared to a seven-day average of 229 hospitalizations as of June 6. DeSantis’ executive order cites a Brown University study to levitra for sale near me support his argument that schools can’t mandate masks. We reached out to DeSantis’ office to confirm the role of that study and to ask if any other research was involved in the development of the executive order. Press secretary Christina Pushaw replied with a statement reiterating the governor’s position that studies have shown erectile dysfunction treatment’s spread in schools is typically less than within the larger community and that science has yet to substantiate the effectiveness of masks in reducing what she said was levitra for sale near me “an already very low risk of erectile dysfunction treatment in children.” She acknowledged that the delta variant has been shown to be more transmissible — which means it could increase children’s risk — “but that is only a working theory as no studies have shown that conclusively.” That made us wonder about key elements of the executive order — specifically, whether the Brown study indeed illustrated that mask mandates didn’t prevent transmission of erectile dysfunction treatment and if it’s correct that “forcing students to wear masks lacks a well-grounded scientific justification.” The Brown Study We reached out to Emily Oster, a professor of economics at Brown University, and the lead author of the study that DeSantis’ order references.

Oster became well known during the levitra for issuing data-driven recommendations on parenting and schooling. Some experts, though, have taken issue with her being an economist and not an epidemiologist. Oster told us she couldn’t participate in a direct interview levitra for sale near me about the study, but she sent us this statement. €œWe did not consult with Gov.

DeSantis on these issues. Our paper levitra for sale near me is currently a pre-print, undergoing peer review. It relies on data from the 2020-2021 school year, prior to the emergence of the more contagious delta variant. Current CDC guidance, taking into account the current levitra situation and all available data on masking, suggests masking for all K-12 students and staff, regardless of vaccination status.” The study analyzed whether mask mandates in school districts in Florida and other states influenced the number of erectile dysfunction treatment cases among students and staff members by looking at mitigation strategies as well as erectile dysfunction treatment case counts.

The researchers found that staff rates of erectile dysfunction treatment levitra for sale near me were slightly higher in districts without mask mandates, but the difference was not statistically significant. Overall, no correlation was found between mask mandates and erectile dysfunction treatment cases in students. But within the study itself, the authors wrote about the limitations of their methods levitra for sale near me. For instance, the study looked only at whether mandates existed at particular schools — not at the mask-wearing behavior of students and staffers.

The study also didn’t account for mitigation measures that might have been in place in the surrounding community, which would influence case counts. At the end of levitra for sale near me the study, the authors offer a conclusion that undermines the executive order. €œWe would emphasize that in general this literature suggests in-person school can be operated safely with appropriate mitigation, which typically includes universal masking. It would be premature to draw any alternative conclusions about this question based on this preliminary data.” Justin Lessler, an epidemiology professor at the University of North Carolina, who led a peer-reviewed study that found masking in schools was associated with a significantly reduced risk of erectile dysfunction treatment transmission, said he didn’t think this Brown study showed any strong conclusions to support the governor’s position.

€œI think the lack of correlation with mask mandates at the population level is pretty weak levitra for sale near me evidence,” Lessler wrote in an email. €œAlso, mechanistically, it is a little hard to believe masking would not have some effect.” Other Studies on Masks in Schools and erectile dysfunction treatment in Children Dr. Lynn Goldman, dean of the Milken Institute of Public Health at George Washington University, said masks are absolutely effective in reducing erectile dysfunction treatment transmission in children. €œWhat the science actually shows is that for children ages 2 and levitra for sale near me above, masks are not only protective but needed,” said Goldman, who is also a pediatrician.

Since “those kids who are below the age of 12 cannot yet have the treatment so they don’t have that layer of protection.” Goldman also said studies show masking is effective in preventing erectile dysfunction treatment transmission in schools. The CDC guidance also cites several CDC-led studies that show the benefits of levitra for sale near me masking in schools, while independent researchers have shown similar results. Masking was often combined with other efforts to reduce spread, including improved ventilation and fiation systems. These points counter a claim central to DeSantis’ executive order.

That the CDC school-reopening guidance “lacks a well-grounded scientific justification.” “I think this ‘whereas’ of DeSantis’ executive order levitra for sale near me is just false, it’s just patently false,” said Dr. Jeffrey Goldhagen, a pediatrics professor at the University of Florida Health in Jacksonville. What About Risks for Children?. Though studies early in the levitra did seem to indicate levitra for sale near me children were less likely to get erectile dysfunction treatment than adults, current CDC data suggests that no longer seems to be the case.

CDC data through March 2021 shows that erectile dysfunction treatment and symptomatic illness in children ages 5 to 17 was comparable to and illness in adults ages 18 to 49. Studies have also shown that even if children have mild or asymptomatic cases of erectile dysfunction treatment they can spread the disease to adults who may then develop more severe cases — meaning children can be significant vectors of disease. Children also levitra for sale near me are susceptible to the delta variant, which is more transmissible than the alpha variant. Goldhagen said he has already anecdotally heard and seen the spread of the delta variant among children in camps and in schools that have started their semesters.

Pediatric erectile dysfunction treatment levitra for sale near me hospitalizations have also been increasing in Florida in the past week, likely due to the delta variant, and there are reports that some children are experiencing serious symptoms. €œThe increase in the number of patients that we have in our children’s hospital due to erectile dysfunction treatment has increased 500%,” Goldhagen, who is also a pediatrician at Wolfson Children’s Hospital in Jacksonville, told us on Aug. 5. Our Ruling DeSantis’ July 30 executive order missed the mark with its claim that “forcing students to wear masks levitra for sale near me lacks a well-grounded scientific justification.” It also cited a Brown University study as scientific evidence that there is no correlation between mask mandates and reduced erectile dysfunction treatment spread.

However, while that study didn’t show a correlation, its authors noted the study’s limitations and concluded that appropriate mitigation typically includes universal masking. It flatly stated it would be premature to draw other conclusions based on the researchers’ preliminary data. Multiple studies also show masking in schools does have levitra for sale near me an effect on preventing erectile dysfunction treatment transmission. DeSantis’ executive order cherry-picked a study that offers little basis for his position and includes a variety of elements that are not accurate.

We rate this False. Source ListABC levitra for sale near me Science Collaborative, Final Report, June 2021Bloomberg, “Florida Parents Sue DeSantis, Ask Court to Allow Mask Mandates,” Aug. 8, 2021Centers for Disease Control and Prevention, Mask Use and Ventilation Improvements to Reduce erectile dysfunction treatment Incidence in Elementary Schools — Georgia, November 16-December 11, 2020, May 28, 2021Centers for Disease Control and Prevention, erectile dysfunction treatment in Primary and Secondary School Settings During the First Semester of School Reopening — Florida, August-December 2020, March 26, 2021Centers for Disease Control and Prevention, Trends in Number of erectile dysfunction treatment Cases and Deaths in the US Reported to CDC, by State/Territory, accessed Aug. 9, 2021Centers for Disease Control and Prevention, Guidance for erectile dysfunction treatment Prevention in K-12 Schools, updated July 9, 2021Centers for Disease Control and Prevention, Science levitra for sale near me Brief.

Transmission of erectile dysfunction in K-12 Schools and Early Care and Education Programs – Updated, July 9, 2021Centers for Disease Control and Prevention, Estimated erectile dysfunction treatment Burden, updated July 27, 2021Department of Health and Human Services, Protect Public Data Hub — Hospital Utilization, accessed Aug. 9, 2021Email interview with Justin Lessler, epidemiology professor at the University of North Carolina-Chapel Hill, Aug. 5, 2021Email interview with Jill Roberts, levitra for sale near me associate professor at the University of South Florida College of Public Health, Aug. 3, 2021Email statement from Emily Oster, economics professor at Brown University, Aug.

3, 2021Email statement from Christina Pushaw, press secretary for Gov. Ron DeSantis, levitra for sale near me Aug. 4, 2021Harvard Medical School, erectile dysfunction Outbreak and Kids, Aug. 2, 2021medRxiv, erectile dysfunction treatment Mitigation Practices and erectile dysfunction treatment Rates in Schools.

Report on Data From Florida, New York levitra for sale near me and Massachusetts, May 21, 2021The Miami Herald, “Florida Children’s Hospitals See Pediatric erectile dysfunction treatment Cases Soar Amid Delta Variant Surge,” updated Aug. 9, 2021National Bureau of Economic Research, School Reopenings, Mobility, and erectile dysfunction treatment Spread. Evidence From Texas, levitra for sale near me May 2021NBC 6 South Florida, “‘Governor Who?. €™ Biden Hits Back at DeSantis as Feud Continues,” Aug.

6, 2021The New York Times, “She Fought to Reopen Schools, Becoming a Hero and a Villain,” June 22, 2021Office of Gov. Ron DeSantis, “Governor DeSantis Issues an Executive Order Ensuring Parents’ Freedom to Choose,” July 30, 2021Phone interview with Katherine Drabiak, associate professor at the University of South Florida levitra for sale near me College of Public Health, August 3, 2021Phone interview with Dr. Jeffrey Goldhagen, pediatrics professor at the University of Florida Health in Jacksonville, Aug. 5, 2021Phone interview with Dr.

Lynn Goldman, dean of the Milken Institute School of Public Health at levitra for sale near me George Washington University, Aug. 6, 2021Reuters, “Florida Governor Blocks School Mask Mandates, Says Parents Can Choose,” July 31, 2021Science, “Household erectile dysfunction treatment Risk and In-Person Schooling,” June 4, 2021 [UPDATED at 1 p.m. ET on Aug. 11.

This story has been updated with newly released numbers on erectile dysfunction treatment case counts from the Florida Department of Health for the week ending Aug. 5. The fact check originally cited a CDC one-day case tally that has since been lowered to 19,584, which the health department disputes, citing its own tally of 15,319.] Victoria Knight. vknight@kff.org, @victoriaregisk Related Topics Contact Us Submit a Story TipHospitals coast to coast are demanding their employees get vaccinated against erectile dysfunction treatment as the highly contagious delta variant tears through populations with low vaccination rates.

Nearly 1,500 hospitals — roughly a quarter of all hospitals in the U.S. €”now require staffers to get a erectile dysfunction treatment, said Colin Milligan, a spokesperson for the American Hospital Association. More follow suit every day as hospital leaders aim to head off staff shortages like those experienced last year and to keep employees from becoming vectors of the disease. But that’s not an option in Montana, where a law passed this year amid a levitra backlash prohibits employers, including most health care facilities, from mandating any treatment for their staffs.

Nor is it in Oregon, where a 32-year-old law similarly bans treatment mandates for health workers. At least seven states have enacted laws to prevent erectile dysfunction treatment mandates or so-called treatment passports that would provide proof of vaccination, according to the National Academy for State Health Policy. Most restrict only state and local governments or specifically exempt health care facilities, but Montana’s law goes further. It prohibits employers — including hospitals — from discriminating against a worker based on vaccination status.

Employers can’t require vaccinations and workers don’t have to tell their bosses whether they’re vaccinated. That worries hospital leaders as erectile dysfunction treatment hospitalizations hit levels not seen nationally since February. In Montana, erectile dysfunction treatment hospitalizations had nearly doubled at the beginning of August compared with two weeks before, and about 90% of erectile dysfunction treatment patients hospitalized at the end of July hadn’t been vaccinated, according to the Montana health department’s most recent data. €œI cannot imagine passing any worse law than that,” said John Goodnow, CEO of Benefis Health in Great Falls.

€œImagine if that would have been passed back when we were fighting polio, or smallpox before that.” Benefis had announced plans to make the treatment mandatory for its 3,400 staffers back in April, before state lawmakers passed the bill preventing the hospital from doing so. Those who back the law said it’s an issue of personal rights. €œYour health care decisions are private, they’re protected by the constitution of the state of Montana,” Rep. Jennifer Carlson, a Republican, said in March as she introduced the bill.

€œAnd your religious rights are protected.” Health care professionals are more likely to be vaccinated against erectile dysfunction treatment than the general population. Nonetheless, there remain nurses, doctors and other hospital employees who work directly with patients who are hesitant or resistant to inoculation, especially in rural regions. Dr. Greg Tierney, chief medical officer of Benefis, said he’s concerned about potential rancor between vaccinated and unvaccinated staff members as their workload rises with the caseload.

€œYou have the people who have been vaccinated looking at the person next to him who’s choosing not to,” Tierney said. €œWhereas, they were literally brethren in arms.” In northwestern Montana, a region with a 34% vaccination rate to date and the epicenter of the state’s latest surge, Logan Health officials said existing staffing shortages are worsening as health care workers become infected or must quarantine. Chief medical officer Dr. Doug Nelson said the shots have been proven safe and effective, and Logan would likely consider a staff treatment mandate if state law allowed it.

€œWearing a mask whenever you’re in our facilities, that helps, but being able to vaccinate everyone would help more,” Nelson said. In Billings, Montana’s most populated city, the Billings Clinic’s intensive care unit reached capacity the first week of August and officials started shifting patients to overflow beds. At that time, roughly 60% of the system’s employees reported being vaccinated. Hospital leaders are hosting weekly town halls to answer clinic workers’ treatment questions or try to dispel myths in between caring for a growing number of erectile dysfunction treatment patients.

€œKnowing there are solutions out there that can help prevent this from happening, like simple vaccination, makes you frustrated,” said Dr. Fernando Caceres, an intensivist in Billings Clinic’s ICU. In July, nearly 60 major U.S. Medical organizations called for employers to mandate all health and long-term care workers get vaccinated in a joint statement that included the American Medical Association and the American Nurses Association.

The Department of Veterans Affairs gave health care personnel eight weeks to get the shot. In August, California became the first state to order workers in health care settings to be fully vaccinated and for visitors in health settings to show proof of vaccination or a negative erectile dysfunction treatment test. And in Massachusetts, Republican Gov. Charlie Baker ordered most nursing home workers to get the jab by October 10, citing a massive increase in cases among staffers and residents.

Some hospitals have had to enforce their mandates. In Texas in June, Houston Methodist fired or accepted the resignations of more than 150 health care workers who didn’t get the jab. Trinity Health — a Catholic health system with 117,000 workers across 22 states — said employees without a shot or exemption would be fired. €œTrinity Health has counted our own colleagues and patients in the too-high erectile dysfunction death toll,” Mike Slubowski, the organization’s president and CEO, said in the announcement.

€œNow that we have a proven way to prevent erectile dysfunction treatment deaths, we are not hesitating to do our part.” How Trinity’s policy will work in Oregon, where the three-decade-old law prevents treatment requirements, is unclear Attempts to change the law won’t happen before next year’s legislative session, Democratic Gov. Kate Brown said. In the meantime, she issued a rule last week to pressure health care workers to get vaccinated, saying they will face weekly erectile dysfunction treatment tests if they don’t — and their employers will foot the bill. €œThis new safety measure is necessary to stop delta from causing severe illness among our first line of defense.

Our doctors, nurses, medical students and frontline health care workers,” Brown said in the statement. Before Brown’s announcement, Kaiser Permanente, a national health system based in California, had said all of its employees must be vaccinated against erectile dysfunction treatment — even those in Oregon. (KHN, which produces California Healthline, is not affiliated with Kaiser Permanente.) After Brown’s announcement, KP spokesperson Michael Foley said those who don’t get the treatment in Oregon will undergo weekly testing. Employees in other states, however, will have to apply for medical or religious exemptions or find a new job if they refuse to be vaccinated.

Katheryn Houghton. khoughton@kff.org, @K_Hought Related Topics Contact Us Submit a Story TipSeveral orthopedic surgeons who invested in Renovis Surgical Technologies made big money when a Japanese technology giant snatched up the small California medical device company. Kyocera Corp., which was eager to expand its U.S. Spine and joint implant sales, bought Renovis’ assets in 2019.

While the parties kept the sale price under wraps, Renovis’ physician stockholders held stakes valued at over $34 million by the end of that year, with nearly half that sum to company founder and chief executive Dr. John Steinmann, according to the federal government’s “Open Payments” database, which tracks payments to doctors from device and drug companies. Hundreds of orthopedists and neurosurgeons have cashed in on stakes in companies that design, manufacture or distribute orthopedic implants — sometimes after investing little or no money — and despite ongoing ethical and legal concerns, a KHN investigation has found. KHN found that surgeons had stakes in more than 200 privately owned device companies from 2013 through 2019.

At the end of 2019, their holdings topped $300 million in value. Doctors can dispute the payments but rarely do so. Device makers often reach out to orthopedic surgeons for help designing or evaluating new implants, a practice they say spurs innovation and leads to safer, more durable devices. Offering feedback can land surgeons lucrative royalty and consulting deals or stock holdings that escalate in value when startup device companies are sold.

In other cases, surgeons have owned a piece of distributorships that buy implants from manufacturers and resell them at a profit. [embedded content]Dr. John Steinmann speaks during a Senate Finance Committee hearing on Nov. 17, 2015.

Whistleblowers and government fraud fighters have argued for years that money passing from industry to doctors can corrupt medical judgment, inflate costs and lead to unnecessary operations or otherwise harm patients. Some of the harshest criticism has been directed at surgeons who profit from the sale of orthopedic devices — from spinal implants and screws and other hardware to artificial knees and hips that typically cost thousands of dollars. Federal officials warned as far back as 2013 that these sales could violate federal anti-kickback laws. Steinmann, a Southern California orthopedic surgeon, has been a staunch defender of the profitable distribution companies and has held a stake in at least nine of them, according to Open Payments data.

He and four other surgeons at Arrowhead Orthopedics in Redlands, California, were paid nearly $2.5 million in “dividend, profit or other return on investment” by a single distributorship of implants in 2019, according to the database. The biggest surgeon investors in implant maker Renovis also owned a stake in distributorships. Steinmann received $16.4 million in “ownership and investment interest” from Renovis in 2019, according to Open Payments data, which says he invested $6.7 million in the company. Five other surgeons had holdings worth $1 million or more, according to the data.

Steinmann told KHN that he and the other surgeons invested millions in Renovis and worked for years building it. €œWe earned every dollar that we made,” he said. Renovis developed innovative products over a decade and the investment return was “good, but not out of line in any respect,” Steinmann said. He added.

€œI didn’t do any better than if I invested in the stock market. I don’t think it is fair to say otherwise.” In testimony before Congress, Steinmann has conceded that a few “bad apples” may have endangered patients by performing needless, or overly complex, operations for quick profits on implant sales, but testified his distribution companies have operated legally and ethically and have saved hospitals millions of dollars on implants. Critics counter that surgeons should collect only professional fees for operating on patients — and steer clear of taking profits from devices they choose to implant in patients. Orthopedic and neurosurgeons typically earn upward of $500,000 annually for their professional services and are among the highest-paid specialists in medicine.

€œDoing surgery is a loss leader for what you can get for selling your own products,” said Dr. James Rickert, an orthopedic surgeon and head of the Society for Patient Centered Orthopedics, an advocacy group. A ‘Crowded and Cutthroat Field’ The orthopedic surgery industry is awash in cash. More than $3.1 billion flowed from device makers to surgeons from August 2013 through 2019, according to KHN’s analysis of payments that device makers reported to the government-run website.

Much of that money paid surgeons for consulting work, including helping to market new products to their peers, or royalties for inventing or fine-tuning surgical tools. €œOrthopedic surgeons are the type who design things. That is inherent in their nature,” said Mark Weiss, a California lawyer who represents physicians. They also accounted for nearly a third of physicians with stakes in device and drug companies of $250,000 or more during 2019.

While some surgeons lost money, many saw their stakes in these companies shoot up in value. Consider Parcus Medical, a Sarasota, Florida device maker with a self-described “lust for innovation and creativity.” Parcus, which takes its name from the Latin word for “thrifty,” specializes in implants for repairing sports injuries. Massachusetts-based Anika Therapeutics swallowed it for $35 million in January 2020, and 22 surgeon investors saw their Parcus holdings at least triple in value, Open Payments records show. Dr.

Brian McKeon, a Waltham, Massachusetts, orthopedic surgeon and former head physician for the Boston Celtics of the NBA, held Parcus stock in 2019 valued at just over $1.4 million based on an investment of $146,000, according to the Open Payments database. The site states that McKeon did not dispute the figures as posted. But in an email to KHN, McKeon called the Open Payments numbers “way off,” adding “if you find that money please forward to me.” He said he invested in the company in 2006 and has disclosed ownership interest to his patients. Dr.

Brian McKeon (left), an orthopedic surgeon and former head physician for the Boston Celtics of the NBA, held Parcus stock in 2019 valued at just over $1.4 million based on an investment of $146,000, according to the Open Payments database.(Jim Davis / The Boston Globe via Getty Images) Also in January 2020, Anika Therapeutics paid $60 million for implant company Arthrosurface, which had about 20 surgeon investors. Nine paid just $1 for their shares of stock, according to the company. These investments grew in value from $12,600 to $151,200 in 2019, depending on the surgeon, Open Payments records show. Mark Namaroff, Anika’s executive director for investor relations and corporate communications, said that most of the surgeons invested in the companies prior to the acquisition.

€œIt was also our understanding that Arthrosurface granted certain surgeons (likely those referenced as paying $1 for stock) common stock in the company during the company’s early years as compensation for services rendered or inventions assigned to the company. As the investments by these individuals all took place prior to our purchase of the companies, we can’t provide additional information about them,” he wrote in an email. Both Parcus and Arthrosurface had prominent sports orthopedists among their owners, including a dozen who have served as medical consultants to professional sports or U.S. Olympic teams.

It is legal for doctors to work for, or own a piece of, a medical business as long as their compensation is not tied to the volume of its products they use and provided that medical decisions are made in the best interests of patients. Several surgeons’ organizations encourage members to keep detailed records of the services they provide, accept only “fair market” compensation from device makers, and fully disclose industry ties to patients and their peers in scientific journal articles and professional meetings. Device companies are not required to specify what work surgeons did to justify their stock awards, which more than 100 companies have granted to one or more surgeons who invested $100 or less, according to Open Payments data. Stock can skyrocket in value after a device company’s sale.

That happened with Titan Spine, a titanium implant maker in Mequon, Wisconsin, bought by industry giant Medtronic in June 2019. In all, two dozen physician investors received more than $17 million in payments. The company reported that a few who put up no money of their own between 2014 and 2019 gained shares worth hundreds of thousands of dollars. One was Dr.

Andrew Cappuccino, an orthopedic surgeon and team doctor for the NFL’s Buffalo Bills, who received “vested LLC units” valued at $387,500, according to the company’s report to Open Payments for 2019. Cappuccino had no comment. Dr. Andrew Cappuccino (right), an orthopedic surgeon and team doctor for the NFL’s Buffalo Bills, received “vested LLC units” valued at $387,500, according to the company’s report to Open Payments for 2019.

(Rick Stewart / Getty Images) A spokesman for Medtronic said. €œCollaboration with physicians is critical to innovation and the development of medical devices that save and improve the lives of patients, as well as the training of surgeons who use them.” Not all investors were happy with their financial gains, however. Utah orthopedic surgeon Dr. Kade Huntsman is among a group of doctors and former Titan sales executives suing the company, for which he once worked as a consultant.

The lawsuit calls Titan a “glittering Cinderella success story in an otherwise crowded and cutthroat spinal implant field.” Huntsman argues he dwelt on the “dark side” of the fairy tale after spending years providing “the voice, prestige and reputation” that made Titan’s products appealing to surgeons. In legal filings, Huntsman said a Titan sales executive brought him into the fold in April 2014 and persuaded him to try out a Titan device in the operating room. He was so impressed with it that he quickly became “one of the company’s top utilizers” of hardware, according to the suit. Through his lawyer, Huntsman declined to comment.

Huntsman said in the lawsuit that Titan regarded him as a “potential game-changing advocate” for its implants. He talked up Titan’s products at spinal surgery conferences and later taught other surgeons how to use them, according to the suit. Huntsman agreed to help develop a new spinal fusion implant for Titan and was “certain it would be groundbreaking” — so much so that he declined a salary in favor of company “membership units,” according to the suit. But he alleged that Titan executives restructured his holdings, so that upon the sale to Medtronic for more than $150 million he saw a return of $180,000, “far less than the $828,750 he calculated he was entitled to receive,” according to the suit.

Medtronic denied the allegations and filed a motion to dismiss the case. In June, a judge in Milwaukee dismissed most of the case. Medtronic and Titan are opposing a bid by the plaintiffs to amend their complaint, calling it “futile,” court records state. €˜Corruption of Their Medical Judgment’ More than a decade ago, then-New Jersey Attorney General Anne Milgram investigated global device maker Synthes for failing to disclose stock payments to surgeons conducting pre-market trials on orthopedic hardware.

She called that a conflict of interest and a “betrayal of the public trust [that] has the potential to jeopardize patient well-being.” The case centered on a spinal implant from Spine Solutions, a company partly financed by New York investment firm Viscogliosi Brothers. According to Milgram, Viscogliosi Brothers had offered the researchers “substantial investment opportunities in Spine Solutions, as well as consulting contracts that included gifts of company stock and stock options.” Milgram argued that Synthes failed to tell the Food and Drug Administration about the stock payments after it bought Spinal Solutions for $350 million in February 2003. The FDAapproved the device in 2006 largely on the basis of research results. In May 2009, Synthes settled the New Jersey investigation by agreeing to disclose any payments to physician researchers.

Viscogliosi Brothers, which went on to help finance other spinal device startups, was not a defendant in the New Jersey case. But one of its companies, Paradigm Spine, later was accused by a former sales executive of paying kickbacks through “investor opportunities” offered to dozens of spine surgeons. The surgeons were selected “because they are in a position to generate substantial business for Paradigm, and they have done so,” according to the whistleblower’s suit, which said four of Paradigm’s top 10 users were investors. €œThis is a corruption of their medical judgment,” according to the suit.

The whistleblower also accused Paradigm of prompting surgeons to try an implant for an unapproved use and bill for the operation improperly, allegations the company denied. In May 2016, Paradigmagreed to pay the government $585,000 to settle the errant billing claims, court records show. It denied any wrongdoing. Paradigm Spine was sold to RTI Surgical, a Florida device company, in March 2019 for $300 million.

A few surgeon investors wound up with $1 million or more in “ownership and investment interest,” though the company reported that many of the surgeons saw their holdings shrink in value. When Surgeons Profit Off Implant Sales The Front Range Center for Brain &. Spine Surgery in Fort Collins, Colorado, uses implants supplied by Highline Surgical Solutions LLC, whose owners include three of the center’s surgeons, according to Open Payments filings. The doctors say their stakes in the implant company and other medical businesses, including two local surgery centers and a diagnostic imaging center, assure them of a “strong influence on the quality, cost and effectiveness” of medical services.

Highline Surgical Solutions also generated a total of more than $3 million for five surgeons from 2016 through 2020, according to Open Payments data. The Front Range Center discloses the ownership ties and notes patients “will not be treated any differently” should they ask for products from other sources. The Front Range Center had no comment. A few companies have joined the American Association of Surgeon Distributors, a nonprofit group advised by Steinmann that has set standards for “ethical and legal” physician-owned implant distributors.

Most of the distributorships with ties to Steinmann have been members, according to the distributors’ association website. As of 2018, Renovis was listed on the association’s website as a “corporate member.” The association argues that the nation’s five largest orthopedic device companies have established an “oligopoly” that its members fight to compete with, offering “meaningful” cost savings. Steinmann has presented state and federal regulators with research papers that hesays document these savings and show how these companies can be run legally and ethically, by taking steps such as forbidding a distributorship from pressuring physician owners to use its products. €œThere is a right way and a wrong way,” Steinmann said.

Yet the U.S. Department of Health and Human Services Office of Inspector General has argued that physician ownership in device distributors tends to prompt costlier and more-complex surgeries, calling the practice “inherently suspect” in 2013. Last December, officials said these deals could violate anti-kickback laws and “induce physician owners to perform more procedures (or more extensive procedures)” and use its products “in lieu of other, potentially more clinically appropriate devices.” KHN identified more than three dozen implant supply companies that generated millions of dollars for surgeons from 2013 through 2019. Farallon Surgical LLC, for instance, earned three California surgeons more than $7 million from 2014 through 2020, Open Payments records show.

The surgeons had no comment. About three dozen surgeons have bought stock in the Orthopaedic Implant Co., of Reno, Nevada. Most put in $1,250, an investment the company valued at $31,250 for each of those investors in 2019. Company president Itai Nemovicher said the doctors would make money only if the company were sold.

He said the company offers “high-quality implants at a lower price” to benefit patients. €œWe are aboveboard in everything we do,” he said in an interview. Thomas Bulleit, a Washington lawyer who has represented device makers opposed to doctor-owned distributorships, said he sees no reason for physicians to have a stake in the implant supply trade. €œThe problem is doctors steering patients to products that make them money,” he said.

For their part, federal officials told KHN in interviews that they could not comment on any company’s business practices without first reviewing “all of the facts and circumstances on a case-by-case basis.” But they said the inspector general’s office has repeatedly warned physicians about ownership deals that among other things distribute “extraordinary returns on investment compared to the level of risk involved.” Just what is permissible could be clarified by a Justice Department civil case in California that has dragged on for nearly a decade. The suit alleges that Reliance Medical Systems LLC and its non-physician owners paid kickbacks to orthopedic surgeons who agreed to use its products. One surgeon paid nothing for a 20% ownership in one of Reliance’s companies and was paid “an average of more than $500,000 per year between 2007 and 2012,” according to the suit. The suit alleges that 25 of Reliance’s 35 physician investors increased their rate of complex spinal fusions and, in some cases, elderly patients on Medicare suffered complications from operations that were “more extensive than necessary.” Reliance and its owners have repeatedly denied violating any laws.

€œOur clients will never settle. They believe they have done nothing wrong and they want their day in court,” said Reliance attorney Patric Hooper. The trial is set for early 2022. Payments Less Than Transparent While device companies must report physician ownership stakes, patients are largely on their own in deciphering what it all means.

The federal Centers for Medicare &. Medicaid Services, or CMS, which runs the Open Payments website, offers little help. CMS “is unable to speak to how the public should interpret the data,” according to an agency spokesperson. Though it has the authority to do so, CMS has not conducted an audit to verify the accuracy of the reports it receives.

One action CMS took in 2018 suggests that, at least in past years, tens of millions of dollars in orthopedic surgery-related payments was not reported. Responding to written questions, CMS said that in 2018 it contacted about 38,000 orthopedic or neurosurgeons to remind them of the reporting requirements. The action “identified 388 new ownership records associated with 235 physicians, totaling $162,301,018 in reported payments and financial transactions,” according to the agency. €œCMS considered this outreach a success,” the spokesperson said.

Much remains less than transparent, however. Some companies report paying thousands of dollars to surgeon owners one year only to disappear from the database the next. And it is rarely clear what percentage of a device company’s total stock is owned by surgeons who may influence hardware sales, an important legal and ethical distinction. The Open Payments website refers to an ownership interest as a “payment” expressed in dollars but does not always say whether it was paid out in cash or exists only on paper — or how the surgeons obtained their holdings in the company.

Some surgeons apparently invested cash, sometimes hundreds of thousands of dollars. Yet there is no explanation of how some surgeons put up $100 or less for stakes that later soared in value. That makes it all but impossible to know whether the compensation paid to a surgeon was reasonable as required by ethics standards and federal anti-kickback laws. €œThere are legitimate arrangements and possibly illegitimate ones,” said Richard Saver, a University of North Carolina School of Law professor who has studied the reporting system.

€œSeparating the two is proving very difficult.” Fred Schulte. fschulte@kff.org, @fredschulte Related Topics Contact Us Submit a Story Tip.

Can you buy levitra over the counter

Levitra
Forzest
Australia pharmacy price
40
38
Take with high blood pressure
Stuffy or runny nose
Stuffy or runny nose
Effect on blood pressure
11h
11h
For womens
Canadian pharmacy only
Canadian pharmacy only
Female dosage
20mg
20mg
Prescription
RX pharmacy
Pharmacy

Key FindingsThe October KFF Health Tracking can you buy levitra over the counter Poll finds one in http://halytech.net/zithromax-500mg-online/ five adults in the U.S. Report receiving ongoing support for daily activities such as bathing, dressing, or remembering medications, and a similar share say they are providing those type of services for a close friend or family member. About one in five adults (18%) also say they can you buy levitra over the counter or a family member need either new or additional support from paid nurses or aides beyond what they are currently getting. The most common reason why people haven’t gotten the support they need is cost.

More than three-fourths of those who say they need more help (14% of all adults) say “not being able to afford the cost of the care” is a can you buy levitra over the counter reason why they or their family member has not received the additional support from paid nurses or aides.Many unpaid caregivers say providing support to friends or family members has caused them to worry or stress (77%), experience worsening of their own mental health (50%), financial strain due to inability to work (42%), or worsening of their own physical health (38%). Unpaid caregivers are more likely to be racial and ethnic minorities, those with lower education, and report lower levels of household income.Significant shares of older adults in the U.S. Report difficulty paying for various aspects of health care, especially services not generally covered by Medicare. Four in ten older adults (41%) report can you buy levitra over the counter difficulty paying for dental care while three in ten report difficulty affording hearing or vision care (30%).

Dental, vision, and hearing coverage are three benefits not generally covered by Medicare but are part of Democratic lawmakers’ proposals as part of the reconciliation spending package.Many older adults who are eligible for Medicare also report putting off or foregoing medical care due to costs. While Medicare helps older adults pay for routine doctor visits and hospital stays, substantial shares of lower can you buy levitra over the counter income older adults report putting off or foregoing services not covered by Medicare. Overall, more than four in ten older adults in households earning less than $40,000 annually report delaying or going without some form of medical care over the past year due to costs (compared to 24% of older adults with household incomes over $40,000), including dental care (34%), vision care (20%), and hearing services including hearing aids (16%).With substantial shares of the public reporting financial strains associated with help with everyday activities for themselves or family members, and seniors reporting difficulty paying for some health care expenses, the latest KFF poll finds broad support for many of the proposals in the reconciliation package being currently discussed in Congress.Home And Community Based ServicesOne in five adults, including 27% of adults 65 and older, say they are currently receiving ongoing support with everyday activities from either a family member (19%), a friend (11%), or paid nurses or aides (5%). Additionally, nearly four in ten (38%) adults say a family member gets ongoing help from at least one of these sources including another family member (30%), paid nurses or aides (16%) or friends (12%).

About one in five adults (18%) say they or a family member need either new or additional support from can you buy levitra over the counter paid nurses or aides beyond what they are currently getting. The most common reason why people haven’t gotten the support they need is cost. More than three-fourths of those who say they need more help (14% of all adults) say “not being able to afford the cost of the care” is a reason why they or their family member has not received the additional support from paid nurses can you buy levitra over the counter or aides. Other reasons include not being able to find someone to provide the services (47%, or 8% of all adults), being worried about being exposed to erectile dysfunction (40%, 7% of all adults), being afraid or embarrassed to get help (32%, 6%), or being too busy or unable to find the time to get help (20%, 4%).

With many reporting difficulty paying for cost can you buy levitra over the counter of home and community based care, the poll also gauged support for Democratic proposals to increase funding to Medicaid to pay workers and expand home and community-based services (HCBS). Medicaid is the primary payer for long-term services and supports (LTSS), including home and community-based services (HCBS), that help seniors and people with disabilities with daily self-care and independent living needs. Majorities across partisans (79% total, 95% of Democrats, 76% of independents, 67% of Republicans) support increased funding to Medicaid to pay workers and expand home and community-based services (HCBS).The toll On Unpaid CaregiversWith Congress discussing possible new tax credits to help with home and community based care, one in five adults (21%) say they are currently providing unpaid support with everyday activities to either a friend or family member, excluding the type of care young children need. Majorities across can you buy levitra over the counter partisans also favor new tax credit to help people pay for such care (82% total, 94% of Democrats, 80% of independents, 73% of Republicans).The KFF October Tracking Poll finds unpaid caregivers are more likely to be Black or Hispanic (14% and 21%) compared to those who are not unpaid caregivers (10% and 15%).

About eight in ten unpaid caregivers to family and friends do not have a college degree, and about half have household incomes under $40,000. Consistent with recent focus groups conducted by KFF, the poll finds most unpaid caregivers (85%, 18% of all can you buy levitra over the counter adults) report experiencing at least one of several negative outcomes due to their caregiving responsibilities. Over three-fourths of unpaid caregivers (16% of all adults) say they have experienced stress or worry related to the care of the individual they are caring for, with an additional half (11% of all adults) say they have experienced a worsening of their own mental health as a result of providing this ongoing support. About four in ten (9% of total) say they have experienced financial strain, such as losing a job or having to work reduced hours.

A similar share (38% and 8% of total) also say can you buy levitra over the counter they have experienced a worsening of their own physical health. Expanding Medicare BenefitsWith Congress debating changes to the current Medicare program, eight in ten adults—and nearly all older adults—say Medicare is important to them and their family members. This includes can you buy levitra over the counter at least seven in ten adults across partisanship, income groups, and racial and ethnic identity. Significant shares of older adults in the U.S.

Report difficulty paying can you buy levitra over the counter for various aspects of health care, especially services not generally covered by Medicare. Four in ten older adults (41%) report difficulty paying for dental care while three in ten report difficulty affording hearing or vision care (30%). Two in ten report difficulty affording their prescription drugs. Additionally, one-third report difficulty affording their can you buy levitra over the counter out-of-pocket health care costs and one in five report the same about their monthly health insurance costs – shares comparable to those who report difficulty affording other household expenses such as rent or mortgage, gasoline, monthly utilities, or food and groceries.

Dental services are the most common type of medical care that people have delayed or gone without with about with about one in four (23%) of adults ages 65 and older saying they have put off dental care in the past year due to cost. This is followed can you buy levitra over the counter by vision services or eyeglasses (15%) and hearing aids (13%). Dental, vision, and hearing coverage are three benefits not generally covered by Medicare.Few older adults report delaying or going without a doctor’s office visit (6%), hospital services (5%) or mental health care (2%) due to cost. Overall, three in ten adults 65 and older report delaying or going without certain medical care during the past year due to cost (32%).

Even among older adults who are eligible for Medicare, those with lower incomes report delaying or going can you buy levitra over the counter without care at higher rates. More than four in ten older adults in households earning less than $40,000 annually report delaying or going without some form of medical care over the past year due to costs (compared to 24% of older adults with household incomes over $40,000). While Medicare helps older adults pay for routine doctor visits and hospital stays, substantial shares of lower income older adults report putting off or foregoing dental care (34%), vision care (20%), and hearing can you buy levitra over the counter services including hearing aids (16%) that are not generally covered by Medicare. A large majority of the public (90%) favor expanding Medicare coverage to include dental, vision, and hearing coverage, including 97% of Democrats, 90% of independents, and 85% of Republicans.

This proposal is also largely favored by adults 65 and can you buy levitra over the counter older, including 96% of those in that age group who identify as Democrats or Democratic-leaning and 82% of their Republican counterparts. Proposals aimed at curbing the price individuals have to pay for their prescription drugs are favored by majorities of the public with at least eight in ten overall and at least three-fourths across partisans saying they favor each of the proposals asked about. Eighty-eight percent of adults favor limiting how much drug companies can increase the price for prescription drugs each year to not outpace the rate of inflation (including 93% of Democrats, 86% of independents, 89% of Republicans) and a similar share (85%) favor placing an annual limit on out-of-pocket prescription drug costs for people on Medicare (favored by 88% of Democrats, 85% of independents, 84% of Republicans). The proposed changes to Medicare drug negotiations as part of the reconciliation package can you buy levitra over the counter poll findings were released earlier this week.The Affordable Care ActViews of the 2010 Affordable Care Act are still largely driven by party identification with nearly nine in ten Democrats saying they view the law favorably, while three-fourths of Republicans say they hold an unfavorable view.

Independents are slightly more favorable than unfavorable with more than half saying they hold a positive opinion of the ACA. KFF has been polling can you buy levitra over the counter on the ACA since its passage and since 2017 views have been more favorable than unfavorable but still sharply divided on party lines. The erectile dysfunction treatment relief bill passed in early March 2021 providing additional financial help for people who buy their own health insurance coverage. Previous KFF polling found that a small minority of those likely eligible for additional financial help or coverage reporting going online to see if they qualify for a different or cheaper health insurance plan.Among those under 65 years old, nine percent of those who are either uninsured or buy their own coverage reported going online in the in the two months before mid-May 2021 to see if they qualify for a different or cheaper health insurance plan or Medicaid as part of the erectile dysfunction treatment relief package.

Four months later, the latest KFF polling finds that about one in four (23%) of those likely eligible for this assistance have gone online to see if they qualify, though majorities can you buy levitra over the counter (75%) still have not. In addition, changes to health insurance coverage provided under the Affordable Care Act continue to be seen through a partisan lens, with overwhelming majorities of Democrats and smaller majorities of Republicans expressing support. Overall, eight in ten adults favor making permanent the can you buy levitra over the counter financial help to low- and moderate- income Americans who buy their own health insurance coverage (94% of Democrats, 79% of independents, 63% of Republicans). Three in four favor the federal government stepping in to provide insurance options for lower income people living in states that haven’t expanded their Medicaid programs (94% of Democrats, 76% of independents) but this is supported by a small majority (54%) of Republicans.While the poll finds broad support for many of the Democratic proposed changes to the country’s health care system including the ACA, Medicaid, and Medicare, the poll did not ask about the potential costs and savings associated with each provision, or the size and scope of Democrats’ broader legislative plan, which includes many provisions unrelated to health care.

Key FindingsThe October continue reading this KFF Health Tracking Poll levitra for sale near me finds one in five adults in the U.S. Report receiving ongoing support for daily activities such as bathing, dressing, or remembering medications, and a similar share say they are providing those type of services for a close friend or family member. About one in five adults (18%) also say they or a family member need levitra for sale near me either new or additional support from paid nurses or aides beyond what they are currently getting.

The most common reason why people haven’t gotten the support they need is cost. More than three-fourths of those who say they need more help (14% of all adults) say “not being able to afford the cost of levitra for sale near me the care” is a reason why they or their family member has not received the additional support from paid nurses or aides.Many unpaid caregivers say providing support to friends or family members has caused them to worry or stress (77%), experience worsening of their own mental health (50%), financial strain due to inability to work (42%), or worsening of their own physical health (38%). Unpaid caregivers are more likely to be racial and ethnic minorities, those with lower education, and report lower levels of household income.Significant shares of older adults in the U.S.

Report difficulty paying for various aspects of health care, especially services not generally covered by Medicare. Four in ten older adults (41%) report difficulty paying for dental care while levitra for sale near me three in ten report difficulty affording hearing or vision care (30%). Dental, vision, and hearing coverage are three benefits not generally covered by Medicare but are part of Democratic lawmakers’ proposals as part of the reconciliation spending package.Many older adults who are eligible for Medicare also report putting off or foregoing medical care due to costs.

While Medicare helps older adults pay for routine doctor visits and hospital stays, substantial shares of lower income older adults report putting off or levitra for sale near me foregoing services not covered by Medicare. Overall, more than four in ten older adults in households earning less than $40,000 annually report delaying or going without some form of medical care over the past year due to costs (compared to 24% of older adults with household incomes over $40,000), including dental care (34%), vision care (20%), and hearing services including hearing aids (16%).With substantial shares of the public reporting financial strains associated with help with everyday activities for themselves or family members, and seniors reporting difficulty paying for some health care expenses, the latest KFF poll finds broad support for many of the proposals in the reconciliation package being currently discussed in Congress.Home And Community Based ServicesOne in five adults, including 27% of adults 65 and older, say they are currently receiving ongoing support with everyday activities from either a family member (19%), a friend (11%), or paid nurses or aides (5%). Additionally, nearly four in ten (38%) adults say a family member gets ongoing help from at least one of these sources including another family member (30%), paid nurses or aides (16%) or friends (12%).

About one in five adults (18%) say they or a family member need levitra for sale near me either new or additional support from paid nurses or aides beyond what they are currently getting. The most common reason why people haven’t gotten the support they need is cost. More than three-fourths of those who say they need more help (14% of all adults) say “not being able to afford levitra for sale near me the cost of the care” is a reason why they or their family member has not received the additional support from paid nurses or aides.

Other reasons include not being able to find someone to provide the services (47%, or 8% of all adults), being worried about being exposed to erectile dysfunction (40%, 7% of all adults), being afraid or embarrassed to get help (32%, 6%), or being too busy or unable to find the time to get help (20%, 4%). With many reporting difficulty paying for cost of home and community based care, the poll also gauged support for Democratic proposals levitra for sale near me to increase funding to Medicaid to pay workers and expand home and community-based services (HCBS). Medicaid is the primary payer for long-term services and supports (LTSS), including home and community-based services (HCBS), that help seniors and people with disabilities with daily self-care and independent living needs.

Majorities across partisans (79% total, 95% of Democrats, 76% of independents, 67% of Republicans) support increased funding to Medicaid to pay workers and expand home and community-based services (HCBS).The toll On Unpaid CaregiversWith Congress discussing possible new tax credits to help with home and community based care, one in five adults (21%) say they are currently providing unpaid support with everyday activities to either a friend or family member, excluding the type of care young children need. Majorities across levitra for sale near me partisans also favor new tax credit to help people pay for such care (82% total, 94% of Democrats, 80% of independents, 73% of Republicans).The KFF October Tracking Poll finds unpaid caregivers are more likely to be Black or Hispanic (14% and 21%) compared to those who are not unpaid caregivers (10% and 15%). About eight in ten unpaid caregivers to family and friends do not have a college degree, and about half have household incomes under $40,000.

Consistent with recent focus groups conducted by KFF, the poll finds most unpaid caregivers (85%, 18% of all adults) report experiencing levitra for sale near me at least one of several negative outcomes due to their caregiving responsibilities. Over three-fourths of unpaid caregivers (16% of all adults) say they have experienced stress or worry related to the care of the individual they are caring for, with an additional half (11% of all adults) say they have experienced a worsening of their own mental health as a result of providing this ongoing support. About four in ten (9% of total) say they have experienced financial strain, such as losing a job or having to work reduced hours.

A similar share (38% and 8% of total) also say they have levitra for sale near me experienced a worsening of their own physical health. Expanding Medicare BenefitsWith Congress debating changes to the current Medicare program, eight in ten adults—and nearly all older adults—say Medicare is important to them and their family members. This includes at least seven in ten adults levitra for sale near me across partisanship, income groups, and racial and ethnic identity.

Significant shares of older adults in the U.S. Report difficulty paying for various aspects of health care, especially services not generally covered by Medicare levitra for sale near me. Four in ten older adults (41%) report difficulty paying for dental care while three in ten report difficulty affording hearing or vision care (30%).

Two in ten report difficulty affording their prescription drugs. Additionally, one-third report levitra for sale near me difficulty affording their out-of-pocket health care costs and one in five report the same about their monthly health insurance costs – shares comparable to those who report difficulty affording other household expenses such as rent or mortgage, gasoline, monthly utilities, or food and groceries. Dental services are the most common type of medical care that people have delayed or gone without with about with about one in four (23%) of adults ages 65 and older saying they have put off dental care in the past year due to cost.

This is followed by vision services or eyeglasses (15%) and levitra for sale near me hearing aids (13%). Dental, vision, and hearing coverage are three benefits not generally covered by Medicare.Few older adults report delaying or going without a doctor’s office visit (6%), hospital services (5%) or mental health care (2%) due to cost. Overall, three in ten adults 65 and older report delaying or going without certain medical care during the past year due to cost (32%).

Even among older adults who are eligible for Medicare, those with lower incomes report delaying or going levitra for sale near me without care at higher rates. More than four in ten older adults in households earning less than $40,000 annually report delaying or going without some form of medical care over the past year due to costs (compared to 24% of older adults with household incomes over $40,000). While Medicare helps older adults pay for routine doctor levitra for sale near me visits and hospital stays, substantial shares of lower income older adults report putting off or foregoing dental care (34%), vision care (20%), and hearing services including hearing aids (16%) that are not generally covered by Medicare.

A large majority of the public (90%) favor expanding Medicare coverage to include dental, vision, and hearing coverage, including 97% of Democrats, 90% of independents, and 85% of Republicans. This proposal is also largely favored by adults 65 and levitra for sale near me older, including 96% of those in that age group who identify as Democrats or Democratic-leaning and 82% of their Republican counterparts. Proposals aimed at curbing the price individuals have to pay for their prescription drugs are favored by majorities of the public with at least eight in ten overall and at least three-fourths across partisans saying they favor each of the proposals asked about.

Eighty-eight percent of adults favor limiting how much drug companies can increase the price for prescription drugs each year to not outpace the rate of inflation (including 93% of Democrats, 86% of independents, 89% of Republicans) and a similar share (85%) favor placing an annual limit on out-of-pocket prescription drug costs for people on Medicare (favored by 88% of Democrats, 85% of independents, 84% of Republicans). The proposed changes to Medicare levitra for sale near me drug negotiations as part of the reconciliation package poll findings were released earlier this week.The Affordable Care ActViews of the 2010 Affordable Care Act are still largely driven by party identification with nearly nine in ten Democrats saying they view the law favorably, while three-fourths of Republicans say they hold an unfavorable view. Independents are slightly more favorable than unfavorable with more than half saying they hold a positive opinion of the ACA.

KFF has been polling on the ACA since its passage and since 2017 views have been more favorable than unfavorable but still sharply divided levitra for sale near me on party lines. The erectile dysfunction treatment relief bill passed in early March 2021 providing additional financial help for people who buy their own health insurance coverage. Previous KFF polling found that a small minority of those likely eligible for additional financial help or coverage reporting going online to see if they qualify for a different or cheaper health insurance plan.Among those under 65 years old, nine percent of those who are either uninsured or buy their own coverage reported going online in the in the two months before mid-May 2021 to see if they qualify for a different or cheaper health insurance plan or Medicaid as part of the erectile dysfunction treatment relief package.

Four months later, the latest KFF polling finds that about one in four (23%) of those likely eligible for this assistance have gone online to see if they qualify, though majorities (75%) still levitra for sale near me have not. In addition, changes to health insurance coverage provided under the Affordable Care Act continue to be seen through a partisan lens, with overwhelming majorities of Democrats and smaller majorities of Republicans expressing support. Overall, eight in ten adults favor making permanent levitra for sale near me the financial help to low- and moderate- income Americans who buy their own health insurance coverage (94% of Democrats, 79% of independents, 63% of Republicans).

Three in four favor the federal government stepping in to provide insurance options for lower income people living in states that haven’t expanded their Medicaid programs (94% of Democrats, 76% of independents) but this is supported by a small majority (54%) of Republicans.While the poll finds broad support for many of the Democratic proposed changes to the country’s health care system including the ACA, Medicaid, and Medicare, the poll did not ask about the potential costs and savings associated with each provision, or the size and scope of Democrats’ broader legislative plan, which includes many provisions unrelated to health care. Methodology.

Where can I keep Levitra?

Keep out of the reach of children. Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F). Throw away any unused medicine after the expiration date.

Best place to buy generic levitra

ALBUQUERQUE, N.M best place to buy generic levitra Where to buy cialis in australia. And SALT LAKE CITY, Aug. 6, 2021 /PRNewswire/ -- Twistle best place to buy generic levitra by Health Catalyst, Inc. (Nasdaq. HCAT) ("Twistle"), a secure communication platform that engages patients in their care, will host a variety of activities at the HIMSS21 Global Conference, including product demonstrations, a Pinksocks giveaway, and a Theater Presentation with Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.

Twistle's activities at this year's event are focused on new and innovative ways to eliminate disparities in best place to buy generic levitra healthcare. At Twistle's booth – Consumerism and Patient Engagement Pavilion in Caesar's Forum, booth #C437-38 – HIMSS21 participants are invited to learn how the company's patient engagement software can effectively address health inequities and other barriers to health and wellness. Live demonstrations will illustrate how patient engagement technology can reduce complications, support care plans, improve quality of life, and optimize care outcomes. Visitors to best place to buy generic levitra the Twistle booth can also learn about #pinksocks, a phenomenon that ignited a movement at HIMSS15 and will be continued at this year's event. A limited supply of #pinksocks will be gifted to HIMSS attendees to represent a shared belief that we can all do our part to make a positive impact on the world and change it for the better.Nick Adkins, Co-Founder of Pinksocks Life, Inc., a charitable organization focused on promoting human connection around the world, noted, "To achieve the promise of new approaches to healthcare, it will take all of us—technology companies, pharmaceutical companies, hospitals, research centers, patients, providers—all working together toward a common goal." Lastly, a HIMSS21 Theater Presentation will feature Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.

During the presentation Burton will discuss how Providence is generating patient engagement return on investment (ROI) by improving patient readiness for surgery, resulting in reduced complications, shorter length of stay, reduced readmissions and emergency department visits, and more. This session will be held in the Consumer and Patient Engagement Pavilion on Tuesday, August 10, from 3:45-4:05 pm PT."We best place to buy generic levitra are proud of our work to remove barriers to care for so many patients and we celebrate our health system colleagues in their quest to improve care delivery in innovative ways," said Kulmeet Singh, Founder of Twistle. "I look forward to personally thanking everyone I see at HIMSS for their commitment to a worthy mission."HIMSS is a global health conference and exhibition that focuses on the healthcare ecosystem by connecting professionals for education, innovation, and collaboration. HIMSS21 takes place August 9–13, 2021, in Las Vegas, Nevada.About Twistle by Health CatalystTwistle helps care teams transform best place to buy generic levitra the patient experience, improve quality, and reduce costs through patient-centered, HIPAA-compliant communication. We offer "turn-by-turn" guidance as patients navigate their health journey - before, during, and after a care episode.

A rich library of clinical content and best practices optimizes patient engagement to improve care plan compliance. In addition, Twistle delivers education, coaching, remote patient monitoring, and assessment forms to regularly connect patients best place to buy generic levitra and care teams, delivering a more comprehensive patient experience that saves valuable staff time, improves patient satisfaction and clinical outcomes, decreases avoidable readmissions and ED visits, and reduces the length of stay.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.About Pinksocks LifePinksocks Life, Inc. Is a tax exempt 501(c)(3) charitable organization focused on promoting human connection around the world by socially supporting best place to buy generic levitra other public charities.

The pinksocks movement empowers people from all walks of life to connect with anyone, anywhere, by creating a global tribe of pinksocks-wearing people who are focused on empathy, caring, and love. The movement has been decommoditized from its beginning in 2015 – all pinksocks are gifts. Every connection made between the gift giver and recipient is based on an best place to buy generic levitra authentic connection, not a transaction. View original content to download multimedia:https://www.prnewswire.com/news-releases/twistle-by-health-catalyst-showcases-innovative-ways-to-eliminate-disparities-in-care-at-himss21-301350034.htmlSOURCE Twistle by Health Catalyst MEDIA. Carlene Anteau, MS, RN, VP Marketing, 855-906-4680SALT LAKE CITY, Aug best place to buy generic levitra.

05, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq. HCAT), a best place to buy generic levitra leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2021. €œIn the second quarter of 2021, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA. Our second quarter 2021 Adjusted EBITDA performance of $1.7 million represents the first time since the company’s incorporation that we have achieved positive quarterly Adjusted EBITDA,” said Dan Burton, CEO of Health Catalyst.

€œAdditionally, we best place to buy generic levitra are excited to have closed our recent acquisition of Twistle on July 1, 2021. We anticipate Twistle will meaningfully bolster our Population Health analytics application suite, as healthcare organizations increasingly look for a comprehensive Population Health solution. This is particularly important as healthcare organizations begin to normalize operations outside of erectile dysfunction treatment, with many reprioritizing their transition to value-based care models and optimizing care delivery in virtual settings. We are thrilled to welcome our best place to buy generic levitra highly talented Twistle teammates to Health Catalyst, further enabling our mission to be the catalyst for massive, measurable, data-informed healthcare improvement.” Financial Highlights for the Three Months Ended June 30, 2021 Key Financial Metrics Three Months Ended June 30, Year over Year Change 2021 2020 (in thousands, except percentages, unaudited)GAAP Financial Data. Technology revenue$35,529 $25,487 39%Professional services revenue$24,098 $17,772 36%Total revenue$59,627 $43,259 38%Loss from operations$(32,319) $(15,640) (107)%Net loss$(35,834) $(27,183) (32)%Other Non-GAAP Financial Data:(1) Adjusted Technology Gross Profit$24,256 $17,493 39%Adjusted Technology Gross Margin68 % 69 % Adjusted Professional Services Gross Profit$8,174 $3,730 119%Adjusted Professional Services Gross Margin34 % 21 % Total Adjusted Gross Profit$32,430 $21,223 53%Total Adjusted Gross Margin54 % 49 % Adjusted EBITDA$1,661 $(4,188) 140%_____________________(1) These measures are not calculated in accordance with generally accepted accounting principles in the United States (GAAP).

See the accompanying "Non-GAAP Financial Measures" section below for more information about these financial measures, including the limitations of such measures, and for a reconciliation of each measure to the most directly comparable measure calculated best place to buy generic levitra in accordance with GAAP. Financial Outlook Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure. For the third quarter of 2021, we expect. Total revenue between $59.4 million and $62.4 million, best place to buy generic levitra andAdjusted EBITDA between $(7.5) million and $(5.5) millionFor the full year of 2021, we expect. Total revenue between $236.7 million and $239.7 million, andAdjusted EBITDA between $(12.5) million and $(10.5) millionWe have not reconciled guidance for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and have not provided forward-looking guidance for net loss, because there are items that may impact net loss, including stock-based compensation, that are not within our control or cannot be reasonably predicted.

Quarterly Conference Call Details The company will host a conference call to review the results today, Thursday, August 5, 2021, at 5:00 p.m. E.T. The conference call can be accessed by dialing 1-800-708-4539 for U.S. Participants, or 1-847-619-6396 for international participants, and referencing participant code 50199342. A live audio webcast will be available online at https://ir.healthcatalyst.com/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed. Available Information Health Catalyst intends to use its Investor Relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, the benefits of the Twistle acquisition, the impact of erectile dysfunction treatment on our business and results of operations and our financial outlook for Q3 and fiscal year 2021. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following.

(i) changes in laws and regulations applicable to our business model. (ii) changes in market or industry conditions, regulatory environment and receptivity to our technology and services. (iii) results of litigation or a security incident. (iv) the loss of one or more key customers or partners. (v) the impact of erectile dysfunction treatment on our business and results of operations.

And (vi) changes to our abilities to recruit and retain qualified team members. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to the Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on or about February 25, 2021 and the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021 expected to be filed with the SEC on or about August 6, 2021. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law. Condensed Consolidated Balance Sheets(in thousands, except share and per share data, unaudited) As ofJune 30, As ofDecember 31, 2021 2020Assets Current assets. Cash and cash equivalents$205,095 $91,954 Short-term investments57,661 178,917 Accounts receivable, net46,971 48,296 Prepaid expenses and other assets11,323 10,632 Total current assets321,050 329,799 Property and equipment, net20,198 12,863 Intangible assets, net85,910 98,921 Operating lease right-of-use assets23,450 24,729 Goodwill107,822 107,822 Other assets4,526 3,606 Total assets$562,956 $577,740 Liabilities and stockholders’ equity Current liabilities.

Accounts payable$5,259 $5,332 Accrued liabilities13,979 16,510 Acquisition-related consideration payable— 2,000 Deferred revenue55,594 47,145 Operating lease liabilities2,327 2,622 Contingent consideration liabilities2,625 14,427 Convertible senior notes, net174,811 — Total current liabilities254,595 88,036 Convertible senior notes, net of current portion— 168,994 Deferred revenue, net of current portion894 1,878 Operating lease liabilities, net of current portion22,504 23,669 Contingent consideration liabilities, net of current portion6,827 16,837 Other liabilities2,232 2,227 Total liabilities287,052 301,641 Commitments and contingencies Stockholders’ equity. Common stock, $0.001 par value. 45,611,225 and 43,376,848 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively46 43 Additional paid-in capital1,065,680 1,001,645 Accumulated deficit(789,854) (725,650)Accumulated other comprehensive income32 61 Total stockholders' equity275,904 276,099 Total liabilities and stockholders’ equity$562,956 $577,740 Condensed Consolidated Statements of Operations(in thousands, except per share data, unaudited) Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020Revenue. Technology $35,529 $25,487 $69,368 $50,186 Professional services 24,098 17,772 46,105 38,189 Total revenue 59,627 43,259 115,473 88,375 Cost of revenue, excluding depreciation and amortization. Technology(1) 11,847 8,197 22,672 16,103 Professional services(1) 18,206 14,932 34,719 31,094 Total cost of revenue, excluding depreciation and amortization 30,053 23,129 57,391 47,197 Operating expenses.

Sales and marketing(1) 16,705 12,502 32,356 25,989 Research and development(1) 14,524 12,061 28,869 25,149 General and administrative(1)(2)(3) 22,525 8,113 37,540 17,814 Depreciation and amortization 8,139 3,094 15,953 5,971 Total operating expenses 61,893 35,770 114,718 74,923 Loss from operations (32,319) (15,640) (56,636) (33,745)Loss on extinguishment of debt — (8,514) — (8,514)Interest and other expense, net (3,707) (3,025) (7,659) (3,646)Loss before income taxes (36,026) (27,179) (64,295) (45,905)Income tax (benefit) provision (192) 4 (91) (1,232)Net loss $(35,834) $(27,183) $(64,204) $(44,673)Net loss per share, basic and diluted $(0.80) $(0.71) $(1.45) $(1.19)Weighted-average shares outstanding used in calculating net loss per share, basic and diluted 44,886 38,131 44,381 37,620 Adjusted net loss(4) $(1) $(5,740) (2,754) (11,823)Adjusted net loss per share, basic and diluted(4) $— $(0.15) $(0.06) $(0.31)______________________(1) Includes stock-based compensation expense as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020 Stock-Based Compensation Expense:(in thousands) (in thousands) Cost of revenue, excluding depreciation and amortization. Technology$574 $203 $948 $379 Professional services2,282 890 3,717 1,706 Sales and marketing5,932 3,309 10,750 6,491 Research and development2,676 2,080 4,933 3,962 General and administrative6,263 2,564 10,889 5,249 Total$17,727 $9,046 $31,237 $17,787 (2) Includes acquisition-related costs, net as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020 Acquisition-related costs, net:(in thousands) (in thousands)General and administrative$8,114 $(813) $10,270 $(297)(3) Includes duplicate headquarters rent expense, as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020Duplicate rent expense(in thousands) (in thousands)General and administrative$— $125 $— $125 (4) Includes non-GAAP adjustments to net loss.

Refer to the "Non-GAAP Financial Measures—Adjusted Net Loss Per Share" section below for further details. Condensed Consolidated Statements of Cash Flows(in thousands, unaudited) Six Months EndedJune 30,Cash flows from operating activities2021 2020Net loss$(64,204) $(44,673)Adjustments to reconcile net loss to net cash used in operating activities. Depreciation and amortization15,953 5,971 Loss on extinguishment of debt— 8,514 Amortization of debt discount and issuance costs5,817 2,540 Non-cash operating lease expense1,926 1,569 Investment discount and premium amortization569 267 Provision for expected credit losses398 836 Stock-based compensation expense31,237 17,787 Deferred tax (benefit) provision4 (1,280)Change in fair value of contingent consideration liabilities9,064 (1,568)Settlement of acquisition-related contingent consideration(11,025) — Other(25) 71 Change in operating assets and liabilities. Accounts receivable, net927 (7,179)Deferred costs— 482 Prepaid expenses and other assets(1,548) (2,493)Accounts payable, accrued liabilities, and other liabilities(2,439) (1,056)Deferred revenue7,465 4,475 Operating lease liabilities(2,107) (1,783)Net cash used in operating activities(7,988) (17,520) Cash flows from investing activities Purchase of short-term investments(53,686) (163,346)Proceeds from the sale and maturity of short-term investments174,293 124,150 Acquisition of businesses, net of cash acquired— (15,249)Purchase of property and equipment(8,138) (789)Capitalization of internal use software(1,912) (278)Purchase of intangible assets(770) (1,182)Proceeds from sale of property and equipment12 10 Net cash provided by (used in) investing activities109,799 (56,684) Cash flows from financing activities Proceeds from convertible note securities, net of issuance costs— 222,482 Purchase of capped calls concurrent with issuance of convertible senior notes— (21,743)Repayment of credit facilities— (57,043)Proceeds from exercise of stock options14,076 15,010 Proceeds from employee stock purchase plan2,619 2,408 Payments of acquisition-related consideration(5,360) (748)Net cash provided by financing activities11,335 160,366 Effect of exchange rate on cash and cash equivalents(5) (9)Net increase in cash and cash equivalents113,141 86,153 Cash and cash equivalents at beginning of period91,954 18,032 Cash and cash equivalents at end of period$205,095 $104,185 Non-GAAP Financial Measures To supplement our financial information presented in accordance with GAAP, we believe certain non-GAAP measures, including Adjusted Gross Profit, Adjusted Gross Margin, Adjusted EBITDA, Adjusted Net Loss, and Adjusted Net Loss per share, basic and diluted, are useful in evaluating our operating performance. For example, we exclude stock-based compensation expense because it is non-cash in nature and excluding this expense provides meaningful supplemental information regarding our operational performance and allows investors the ability to make more meaningful comparisons between our operating results and those of other companies.

We use this non-GAAP financial information to evaluate our ongoing operations, as a component in determining employee bonus compensation, and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP measures differently or may use other measures to evaluate their performance. A reconciliation is provided below for each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP.

Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business. Adjusted Gross Profit and Adjusted Gross Margin Adjusted Gross Profit is a non-GAAP financial measure that we define as revenue less cost of revenue, excluding depreciation and amortization and excluding stock-based compensation. We define Adjusted Gross Margin as our Adjusted Gross Profit divided by our revenue. We believe Adjusted Gross Profit and Adjusted Gross Margin are useful to investors as they eliminate the impact of certain non-cash expenses and allow a direct comparison of these measures between periods without the impact of non-cash expenses and certain other non-recurring operating expenses. The following is a reconciliation of revenue, the most directly comparable GAAP financial measure, to Adjusted Gross Profit, for the three months ended June 30, 2021 and 2020.

Three Months Ended June 30, 2021 (in thousands, except percentages) Technology Professional Services TotalRevenue$35,529 $24,098 $59,627 Cost of revenue, excluding depreciation and amortization(11,847) (18,206) (30,053) Gross profit, excluding depreciation and amortization23,682 5,892 29,574 Add. Stock-based compensation574 2,282 2,856 Adjusted Gross Profit$24,256 $8,174 $32,430 Gross margin, excluding depreciation and amortization67 % 24 % 50 %Adjusted Gross Margin68 % 34 % 54 % Three Months Ended June 30, 2020 (in thousands, except percentages) Technology Professional Services TotalRevenue$25,487 $17,772 $43,259 Cost of revenue, excluding depreciation and amortization(8,197) (14,932) (23,129) Gross profit, excluding depreciation and amortization17,290 2,840 20,130 Add. Stock-based compensation203 890 1,093 Adjusted Gross Profit$17,493 $3,730 $21,223 Gross margin, excluding depreciation and amortization68 % 16 % 47 %Adjusted Gross Margin69 % 21 % 49 %Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure that we define as net loss adjusted for (i) interest and other expense, net, (ii) loss on debt extinguishment, (iii) income tax (benefit) provision, (iv) depreciation and amortization, (v) stock-based compensation, (vi) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities, and (vii) duplicate headquarters expense. We view acquisition-related expenses when applicable, such as transaction costs and changes in the fair value of contingent consideration liabilities that are directly related to business combinations as costs that are unpredictable, dependent upon factors outside of our control, and are not necessarily reflective of operational performance during a period. We believe Adjusted EBITDA provides investors with useful information on period-to-period performance as evaluated by management and comparison with our past financial performance and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance.

The following is a reconciliation of our net loss, the most directly comparable GAAP financial measure, to Adjusted EBITDA, for the three months ended June 30, 2021 and 2020. Three Months EndedJune 30, 2021 2020 (in thousands)Net loss$(35,834) $(27,183)Add. Interest and other expense, net3,707 3,025 Loss on extinguishment of debt— 8,514 Income tax (benefit) provision(192) 4 Depreciation and amortization8,139 3,094 Stock-based compensation17,727 9,046 Acquisition-related costs, net(1)8,114 (813)Duplicate headquarters rent expense(2)— 125 Adjusted EBITDA$1,661 $(4,188)_____________________(1) Acquisition-related costs, net includes legal, due diligence, accounting, and consulting fees incurred as part of business combinations, and changes in fair value of contingent consideration liabilities for potential earn-out payments. For additional details refer to Note 2 in our condensed consolidated financial statements.(2) Duplicate rent expense for our corporate headquarters relocation. Adjusted Net Loss Per Share Adjusted Net Loss is a non-GAAP financial measure that we define as net loss adjusted for (i) stock-based compensation, (ii) amortization of acquired intangibles, (iii) loss on extinguishment of debt, (iv) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities, (v) non-cash interest expense related to our convertible senior notes, and (vi) duplicate headquarters rent expense.

We believe Adjusted Net Loss provides investors with useful information on period-to-period performance as evaluated by management and comparison with our past financial performance and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020Numerator. (in thousands, except share and per share amounts)Net loss $(35,834) $(27,183) $(64,204) $(44,673)Add. Stock-based compensation 17,727 9,046 31,237 17,787 Amortization of acquired intangibles 7,045 2,360 14,126 4,510 Loss on extinguishment of debt — 8,514 — 8,514 Acquisition-related costs, net 8,114 (813) 10,270 (297)Non-cash interest expense related to convertible senior notes 2,947 2,211 5,817 2,211 Duplicate headquarters rent expense — 125 — 125 Adjusted Net Loss $(1) $(5,740) $(2,754) $(11,823)Denominator. Weighted-average number of shares used in calculating net loss, basic and diluted 44,886,489 38,130,932 44,381,196 37,619,965 Adjusted Net Loss per share, basic and diluted $— $(0.15) $(0.06) $(0.31) Health Catalyst Investor Relations Contact:Adam BrownSenior Vice President, Investor Relations and FP&A+1 (855)-309-6800ir@healthcatalyst.com Health Catalyst Media Contact:Amanda HundtVice President, Corporate Communicationsamanda.hundt@healthcatalyst.com+1 (575) 491-0974.

ALBUQUERQUE, N.M levitra for sale near me Where to buy cialis in australia. And SALT LAKE CITY, Aug. 6, 2021 /PRNewswire/ -- Twistle by Health levitra for sale near me Catalyst, Inc. (Nasdaq. HCAT) ("Twistle"), a secure communication platform that engages patients in their care, will host a variety of activities at the HIMSS21 Global Conference, including product demonstrations, a Pinksocks giveaway, and a Theater Presentation with Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.

Twistle's activities at this year's event levitra for sale near me are focused on new and innovative ways to eliminate disparities in healthcare. At Twistle's booth – Consumerism and Patient Engagement Pavilion in Caesar's Forum, booth #C437-38 – HIMSS21 participants are invited to learn how the company's patient engagement software can effectively address health inequities and other barriers to health and wellness. Live demonstrations will illustrate how patient engagement technology can reduce complications, support care plans, improve quality of life, and optimize care outcomes. Visitors to the Twistle levitra for sale near me booth can also learn about #pinksocks, a phenomenon that ignited a movement at HIMSS15 and will be continued at this year's event. A limited supply of #pinksocks will be gifted to HIMSS attendees to represent a shared belief that we can all do our part to make a positive impact on the world and change it for the better.Nick Adkins, Co-Founder of Pinksocks Life, Inc., a charitable organization focused on promoting human connection around the world, noted, "To achieve the promise of new approaches to healthcare, it will take all of us—technology companies, pharmaceutical companies, hospitals, research centers, patients, providers—all working together toward a common goal." Lastly, a HIMSS21 Theater Presentation will feature Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.

During the presentation Burton will discuss how Providence is generating patient engagement return on investment (ROI) by improving patient readiness for surgery, resulting in reduced complications, shorter length of stay, reduced readmissions and emergency department visits, and more. This session will be held in the Consumer and Patient Engagement Pavilion on Tuesday, August 10, from 3:45-4:05 pm PT."We are proud of our levitra for sale near me work to remove barriers to care for so many patients and we celebrate our health system colleagues in their quest to improve care delivery in innovative ways," said Kulmeet Singh, Founder of Twistle. "I look forward to personally thanking everyone I see at HIMSS for their commitment to a worthy mission."HIMSS is a global health conference and exhibition that focuses on the healthcare ecosystem by connecting professionals for education, innovation, and collaboration. HIMSS21 takes place August 9–13, 2021, in Las Vegas, Nevada.About Twistle by Health CatalystTwistle helps care teams transform the levitra for sale near me patient experience, improve quality, and reduce costs through patient-centered, HIPAA-compliant communication. We offer "turn-by-turn" guidance as patients navigate their health journey - before, during, and after a care episode.

A rich library of clinical content and best practices optimizes patient engagement to improve care plan compliance. In addition, Twistle delivers education, coaching, remote patient monitoring, and assessment forms to regularly connect patients and care teams, delivering a more comprehensive patient experience that saves valuable staff time, improves patient satisfaction and clinical outcomes, decreases avoidable readmissions and ED visits, and reduces the length of stay.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to levitra for sale near me healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.About Pinksocks LifePinksocks Life, Inc. Is a tax exempt 501(c)(3) charitable organization focused on promoting human connection around the world by socially levitra for sale near me supporting other public charities.

The pinksocks movement empowers people from all walks of life to connect with anyone, anywhere, by creating a global tribe of pinksocks-wearing people who are focused on empathy, caring, and love. The movement has been decommoditized from its beginning in 2015 – all pinksocks are gifts. Every connection made between the gift giver and recipient is based on an levitra for sale near me authentic connection, not a transaction. View original content to download multimedia:https://www.prnewswire.com/news-releases/twistle-by-health-catalyst-showcases-innovative-ways-to-eliminate-disparities-in-care-at-himss21-301350034.htmlSOURCE Twistle by Health Catalyst MEDIA. Carlene Anteau, MS, RN, VP Marketing, 855-906-4680SALT LAKE CITY, levitra for sale near me Aug.

05, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq. HCAT), a leading provider of data and analytics technology levitra for sale near me and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2021. €œIn the second quarter of 2021, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA. Our second quarter 2021 Adjusted EBITDA performance of $1.7 million represents the first time since the company’s incorporation that we have achieved positive quarterly Adjusted EBITDA,” said Dan Burton, CEO of Health Catalyst.

€œAdditionally, we are excited to have closed our recent acquisition of Twistle on July levitra for sale near me 1, 2021. We anticipate Twistle will meaningfully bolster our Population Health analytics application suite, as healthcare organizations increasingly look for a comprehensive Population Health solution. This is particularly important as healthcare organizations begin to normalize operations outside of erectile dysfunction treatment, with many reprioritizing their transition to value-based care models and optimizing care delivery in virtual settings. We are thrilled to welcome our highly talented Twistle teammates to Health Catalyst, further enabling our mission to be the catalyst for massive, measurable, data-informed healthcare improvement.” levitra for sale near me Financial Highlights for the Three Months Ended June 30, 2021 Key Financial Metrics Three Months Ended June 30, Year over Year Change 2021 2020 (in thousands, except percentages, unaudited)GAAP Financial Data. Technology revenue$35,529 $25,487 39%Professional services revenue$24,098 $17,772 36%Total revenue$59,627 $43,259 38%Loss from operations$(32,319) $(15,640) (107)%Net loss$(35,834) $(27,183) (32)%Other Non-GAAP Financial Data:(1) Adjusted Technology Gross Profit$24,256 $17,493 39%Adjusted Technology Gross Margin68 % 69 % Adjusted Professional Services Gross Profit$8,174 $3,730 119%Adjusted Professional Services Gross Margin34 % 21 % Total Adjusted Gross Profit$32,430 $21,223 53%Total Adjusted Gross Margin54 % 49 % Adjusted EBITDA$1,661 $(4,188) 140%_____________________(1) These measures are not calculated in accordance with generally accepted accounting principles in the United States (GAAP).

See the levitra for sale near me accompanying "Non-GAAP Financial Measures" section below for more information about these financial measures, including the limitations of such measures, and for a reconciliation of each measure to the most directly comparable measure calculated in accordance with GAAP. Financial Outlook Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure. For the third quarter of 2021, we expect. Total revenue between $59.4 million and $62.4 million, andAdjusted EBITDA between $(7.5) million and $(5.5) millionFor the full year of 2021, we levitra for sale near me expect. Total revenue between $236.7 million and $239.7 million, andAdjusted EBITDA between $(12.5) million and $(10.5) millionWe have not reconciled guidance for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and have not provided forward-looking guidance for net loss, because there are items that may impact net loss, including stock-based compensation, that are not within our control or cannot be reasonably predicted.

Quarterly Conference Call Details The company will host a conference call to review the results today, Thursday, August 5, 2021, at 5:00 p.m. E.T. The conference call can be accessed by dialing 1-800-708-4539 for U.S. Participants, or 1-847-619-6396 for international participants, and referencing participant code 50199342. A live audio webcast will be available online at https://ir.healthcatalyst.com/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed. Available Information Health Catalyst intends to use its Investor Relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, the benefits of the Twistle acquisition, the impact of erectile dysfunction treatment on our business and results of operations and our financial outlook for Q3 and fiscal year 2021. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following.

(i) changes in laws and regulations applicable to our business model. (ii) changes in market or industry conditions, regulatory environment and receptivity to our technology and services. (iii) results of litigation or a security incident. (iv) the loss of one or more key customers or partners. (v) the impact of erectile dysfunction treatment on our business and results of operations.

And (vi) changes to our abilities to recruit and retain qualified team members. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to the Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on or about February 25, 2021 and the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021 expected to be filed with the SEC on or about August 6, 2021. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law. Condensed Consolidated Balance Sheets(in thousands, except share and per share data, unaudited) As ofJune 30, As ofDecember 31, 2021 2020Assets Current assets. Cash and cash equivalents$205,095 $91,954 Short-term investments57,661 178,917 Accounts receivable, net46,971 48,296 Prepaid expenses and other assets11,323 10,632 Total current assets321,050 329,799 Property and equipment, net20,198 12,863 Intangible assets, net85,910 98,921 Operating lease right-of-use assets23,450 24,729 Goodwill107,822 107,822 Other assets4,526 3,606 Total assets$562,956 $577,740 Liabilities and stockholders’ equity Current liabilities.

Accounts payable$5,259 $5,332 Accrued liabilities13,979 16,510 Acquisition-related consideration payable— 2,000 Deferred revenue55,594 47,145 Operating lease liabilities2,327 2,622 Contingent consideration liabilities2,625 14,427 Convertible senior notes, net174,811 — Total current liabilities254,595 88,036 Convertible senior notes, net of current portion— 168,994 Deferred revenue, net of current portion894 1,878 Operating lease liabilities, net of current portion22,504 23,669 Contingent consideration liabilities, net of current portion6,827 16,837 Other liabilities2,232 2,227 Total liabilities287,052 301,641 Commitments and contingencies Stockholders’ equity. Common stock, $0.001 par value. 45,611,225 and 43,376,848 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively46 43 Additional paid-in capital1,065,680 1,001,645 Accumulated deficit(789,854) (725,650)Accumulated other comprehensive income32 61 Total stockholders' equity275,904 276,099 Total liabilities and stockholders’ equity$562,956 $577,740 Condensed Consolidated Statements of Operations(in thousands, except per share data, unaudited) Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020Revenue. Technology $35,529 $25,487 $69,368 $50,186 Professional services 24,098 17,772 46,105 38,189 Total revenue 59,627 43,259 115,473 88,375 Cost of revenue, excluding depreciation and amortization. Technology(1) 11,847 8,197 22,672 16,103 Professional services(1) 18,206 14,932 34,719 31,094 Total cost of revenue, excluding depreciation and amortization 30,053 23,129 57,391 47,197 Operating expenses.

Sales and marketing(1) 16,705 12,502 32,356 25,989 Research and development(1) 14,524 12,061 28,869 25,149 General and administrative(1)(2)(3) 22,525 8,113 37,540 17,814 Depreciation and amortization 8,139 3,094 15,953 5,971 Total operating expenses 61,893 35,770 114,718 74,923 Loss from operations (32,319) (15,640) (56,636) (33,745)Loss on extinguishment of debt — (8,514) — (8,514)Interest and other expense, net (3,707) (3,025) (7,659) (3,646)Loss before income taxes (36,026) (27,179) (64,295) (45,905)Income tax (benefit) provision (192) 4 (91) (1,232)Net loss $(35,834) $(27,183) $(64,204) $(44,673)Net loss per share, basic and diluted $(0.80) $(0.71) $(1.45) $(1.19)Weighted-average shares outstanding used in calculating net loss per share, basic and diluted 44,886 38,131 44,381 37,620 Adjusted net loss(4) $(1) $(5,740) (2,754) (11,823)Adjusted net loss per share, basic and diluted(4) $— $(0.15) $(0.06) $(0.31)______________________(1) Includes stock-based compensation expense as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020 Stock-Based Compensation Expense:(in thousands) (in thousands) Cost of revenue, excluding depreciation and amortization. Technology$574 $203 $948 $379 Professional services2,282 890 3,717 1,706 Sales and marketing5,932 3,309 10,750 6,491 Research and development2,676 2,080 4,933 3,962 General and administrative6,263 2,564 10,889 5,249 Total$17,727 $9,046 $31,237 $17,787 (2) Includes acquisition-related costs, net as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020 Acquisition-related costs, net:(in thousands) (in thousands)General and administrative$8,114 $(813) $10,270 $(297)(3) Includes duplicate headquarters rent expense, as follows. Three Months EndedJune 30, Six Months EndedJune 30, 2021 2020 2021 2020Duplicate rent expense(in thousands) (in thousands)General and administrative$— $125 $— $125 (4) Includes non-GAAP adjustments to net loss.

Refer to the "Non-GAAP Financial Measures—Adjusted Net Loss Per Share" section below for further details. Condensed Consolidated Statements of Cash Flows(in thousands, unaudited) Six Months EndedJune 30,Cash flows from operating activities2021 2020Net loss$(64,204) $(44,673)Adjustments to reconcile net loss to net cash used in operating activities. Depreciation and amortization15,953 5,971 Loss on extinguishment of debt— 8,514 Amortization of debt discount and issuance costs5,817 2,540 Non-cash operating lease expense1,926 1,569 Investment discount and premium amortization569 267 Provision for expected credit losses398 836 Stock-based compensation expense31,237 17,787 Deferred tax (benefit) provision4 (1,280)Change in fair value of contingent consideration liabilities9,064 (1,568)Settlement of acquisition-related contingent consideration(11,025) — Other(25) 71 Change in operating assets and liabilities. Accounts receivable, net927 (7,179)Deferred costs— 482 Prepaid expenses and other assets(1,548) (2,493)Accounts payable, accrued liabilities, and other liabilities(2,439) (1,056)Deferred revenue7,465 4,475 Operating lease liabilities(2,107) (1,783)Net cash used in operating activities(7,988) (17,520) Cash flows from investing activities Purchase of short-term investments(53,686) (163,346)Proceeds from the sale and maturity of short-term investments174,293 124,150 Acquisition of businesses, net of cash acquired— (15,249)Purchase of property and equipment(8,138) (789)Capitalization of internal use software(1,912) (278)Purchase of intangible assets(770) (1,182)Proceeds from sale of property and equipment12 10 Net cash provided by (used in) investing activities109,799 (56,684) Cash flows from financing activities Proceeds from convertible note securities, net of issuance costs— 222,482 Purchase of capped calls concurrent with issuance of convertible senior notes— (21,743)Repayment of credit facilities— (57,043)Proceeds from exercise of stock options14,076 15,010 Proceeds from employee stock purchase plan2,619 2,408 Payments of acquisition-related consideration(5,360) (748)Net cash provided by financing activities11,335 160,366 Effect of exchange rate on cash and cash equivalents(5) (9)Net increase in cash and cash equivalents113,141 86,153 Cash and cash equivalents at beginning of period91,954 18,032 Cash and cash equivalents at end of period$205,095 $104,185 Non-GAAP Financial Measures To supplement our financial information presented in accordance with GAAP, we believe certain non-GAAP measures, including Adjusted Gross Profit, Adjusted Gross Margin, Adjusted EBITDA, Adjusted Net Loss, and Adjusted Net Loss per share, basic and diluted, are useful in evaluating our operating performance. For example, we exclude stock-based compensation expense because it is non-cash in nature and excluding this expense provides meaningful supplemental information regarding our operational performance and allows investors the ability to make more meaningful comparisons between our operating results and those of other companies.

We use this non-GAAP financial information to evaluate our ongoing operations, as a component in determining employee bonus compensation, and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP measures differently or may use other measures to evaluate their performance. A reconciliation is provided below for each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP.

Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business. Adjusted Gross Profit and Adjusted Gross Margin Adjusted Gross Profit is a non-GAAP financial measure that we define as revenue less cost of revenue, excluding depreciation and amortization and excluding stock-based compensation. We define Adjusted Gross Margin as our Adjusted Gross Profit divided by our revenue. We believe Adjusted Gross Profit and Adjusted Gross Margin are useful to investors as they eliminate the impact of certain non-cash expenses and allow a direct comparison of these measures between periods without the impact of non-cash expenses and certain other non-recurring operating expenses. The following is a reconciliation of revenue, the most directly comparable GAAP financial measure, to Adjusted Gross Profit, for the three months ended June 30, 2021 and 2020.

Three Months Ended June 30, 2021 (in thousands, except percentages) Technology Professional Services TotalRevenue$35,529 $24,098 $59,627 Cost of revenue, excluding depreciation and amortization(11,847) (18,206) (30,053) Gross profit, excluding depreciation and amortization23,682 5,892 29,574 Add. Stock-based compensation574 2,282 2,856 Adjusted Gross Profit$24,256 $8,174 $32,430 Gross margin, excluding depreciation and amortization67 % 24 % 50 %Adjusted Gross Margin68 % 34 % 54 % Three Months Ended June 30, 2020 (in thousands, except percentages) Technology Professional Services TotalRevenue$25,487 $17,772 $43,259 Cost of revenue, excluding depreciation and amortization(8,197) (14,932) (23,129) Gross profit, excluding depreciation and amortization17,290 2,840 20,130 Add. Stock-based compensation203 890 1,093 Adjusted Gross Profit$17,493 $3,730 $21,223 Gross margin, excluding depreciation and amortization68 % 16 % 47 %Adjusted Gross Margin69 % 21 % 49 %Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure that we define as net loss adjusted for (i) interest and other expense, net, (ii) loss on debt extinguishment, (iii) income tax (benefit) provision, (iv) depreciation and amortization, (v) stock-based compensation, (vi) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities, and (vii) duplicate headquarters expense. We view acquisition-related expenses when applicable, such as transaction costs and changes in the fair value of contingent consideration liabilities that are directly related to business combinations as costs that are unpredictable, dependent upon factors outside of our control, and are not necessarily reflective of operational performance during a period. We believe Adjusted EBITDA provides investors with useful information on period-to-period performance as evaluated by management and comparison with our past financial performance and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance.

The following is a reconciliation of our net loss, the most directly comparable GAAP financial measure, to Adjusted EBITDA, for the three months ended June 30, 2021 and 2020. Three Months EndedJune 30, 2021 2020 (in thousands)Net loss$(35,834) $(27,183)Add. Interest and other expense, net3,707 3,025 Loss on extinguishment of debt— 8,514 Income tax (benefit) provision(192) 4 Depreciation and amortization8,139 3,094 Stock-based compensation17,727 9,046 Acquisition-related costs, net(1)8,114 (813)Duplicate headquarters rent expense(2)— 125 Adjusted EBITDA$1,661 $(4,188)_____________________(1) Acquisition-related costs, net includes legal, due diligence, accounting, and consulting fees incurred as part of business combinations, and changes in fair value of contingent consideration liabilities for potential earn-out payments. For additional details refer to Note 2 in our condensed consolidated financial statements.(2) Duplicate rent expense for our corporate headquarters relocation. Adjusted Net Loss Per Share Adjusted Net Loss is a non-GAAP financial measure that we define as net loss adjusted for (i) stock-based compensation, (ii) amortization of acquired intangibles, (iii) loss on extinguishment of debt, (iv) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities, (v) non-cash interest expense related to our convertible senior notes, and (vi) duplicate headquarters rent expense.

We believe Adjusted Net Loss provides investors with useful information on period-to-period performance as evaluated by management and comparison with our past financial performance and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020Numerator. (in thousands, except share and per share amounts)Net loss $(35,834) $(27,183) $(64,204) $(44,673)Add. Stock-based compensation 17,727 9,046 31,237 17,787 Amortization of acquired intangibles 7,045 2,360 14,126 4,510 Loss on extinguishment of debt — 8,514 — 8,514 Acquisition-related costs, net 8,114 (813) 10,270 (297)Non-cash interest expense related to convertible senior notes 2,947 2,211 5,817 2,211 Duplicate headquarters rent expense — 125 — 125 Adjusted Net Loss $(1) $(5,740) $(2,754) $(11,823)Denominator. Weighted-average number of shares used in calculating net loss, basic and diluted 44,886,489 38,130,932 44,381,196 37,619,965 Adjusted Net Loss per share, basic and diluted $— $(0.15) $(0.06) $(0.31) Health Catalyst Investor Relations Contact:Adam BrownSenior Vice President, Investor Relations and FP&A+1 (855)-309-6800ir@healthcatalyst.com Health Catalyst Media Contact:Amanda HundtVice President, Corporate Communicationsamanda.hundt@healthcatalyst.com+1 (575) 491-0974.

Jason levitre

Credit. The New England Journal of Medicine Share Fast Facts This study clears up how big an effect the mutational burden has on outcomes to immune checkpoint inhibitors across many different cancer types. - Click to Tweet The number of mutations in a tumor’s DNA is a good predictor of whether it will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors. - Click to Tweet The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows.

The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs. Checkpoint inhibitors are a relatively new class of drug that helps the immune system recognize cancer by interfering with mechanisms cancer cells use to hide from immune cells. As a result, the drugs cause the immune system to fight cancer in the same way that it would fight an .

These medicines have had remarkable success in treating some types of cancers that historically have had poor prognoses, such as advanced melanoma and lung cancer. However, these therapies have had little effect on other deadly cancer types, such as pancreatic cancer and glioblastoma. The mutational burden of certain tumor types has previously been proposed as an explanation for why certain cancers respond better than others to immune checkpoint inhibitors says study leader Mark Yarchoan, M.D., chief medical oncology fellow. Work by Dung Le, M.D., associate professor of oncology, and other researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Cancer Institute for Cancer Immunotherapy showed that colon cancers that carry a high number of mutations are more likely to respond to checkpoint inhibitors than those that have fewer mutations.

However, exactly how big an effect the mutational burden has on outcomes to immune checkpoint inhibitors across many different cancer types was unclear. To investigate this question, Yarchoan and colleagues Alexander Hopkins, Ph.D., research fellow, and Elizabeth Jaffee, M.D., co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care and associate director of the Bloomberg~Kimmel Institute, combed the medical literature for the results of clinical trials using checkpoint inhibitors on various different types of cancer. They combined these findings with data on the mutational burden of thousands of tumor samples from patients with different tumor types. Analyzing 27 different cancer types for which both pieces of information were available, the researchers found a strong correlation.

The higher a cancer type’s mutational burden tends to be, the more likely it is to respond to checkpoint inhibitors. More than half of the differences in how well cancers responded to immune checkpoint inhibitors could be explained by the mutational burden of that cancer. €œThe idea that a tumor type with more mutations might be easier to treat than one with fewer sounds a little counterintuitive. It’s one of those things that doesn’t sound right when you hear it,” says Hopkins.

€œBut with immunotherapy, the more mutations you have, the more chances the immune system has to recognize the tumor.” Although this finding held true for the vast majority of cancer types they studied, there were some outliers in their analysis, says Yarchoan. For example, Merkel cell cancer, a rare and highly aggressive skin cancer, tends to have a moderate number of mutations yet responds extremely well to checkpoint inhibitors. However, he explains, this cancer type is often caused by a levitra, which seems to encourage a strong immune response despite the cancer’s lower mutational burden. In contrast, the most common type of colorectal cancer has moderate mutational burden, yet responds poorly to checkpoint inhibitors for reasons that are still unclear.

Yarchoan notes that these findings could help guide clinical trials to test checkpoint inhibitors on cancer types for which these drugs haven’t yet been tried. Future studies might also focus on finding ways to prompt cancers with low mutational burdens to behave like those with higher mutational burdens so that they will respond better to these therapies. He and his colleagues plan to extend this line of research by investigating whether mutational burden might be a good predictor of whether cancers in individual patients might respond well to this class of immunotherapy drugs. €œThe end goal is precision medicine—moving beyond what’s true for big groups of patients to see whether we can use this information to help any given patient,” he says.

Yarchoan receives funding from the Norman &. Ruth Rales Foundation and the Conquer Cancer Foundation. Through a licensing agreement with Aduro Biotech, Jaffee has the potential to receive royalties in the future..

Credit. The New England Journal of Medicine Share Fast Facts This study clears up how big an effect the mutational burden has on outcomes to immune checkpoint inhibitors across many different cancer types. - Click to Tweet The number of mutations in a tumor’s DNA is a good predictor of whether it will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors. - Click to Tweet The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows. The finding, published in the Dec.

21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs. Checkpoint inhibitors are a relatively new class of drug that helps the immune system recognize cancer by interfering with mechanisms cancer cells use to hide from immune cells. As a result, the drugs cause the immune system to fight cancer in the same way that it would fight an . These medicines have had remarkable success in treating some types of cancers that historically have had poor prognoses, such as advanced melanoma and lung cancer. However, these therapies have had little effect on other deadly cancer types, such as pancreatic cancer and glioblastoma.

The mutational burden of certain tumor types has previously been proposed as an explanation for why certain cancers respond better than others to immune checkpoint inhibitors says study leader Mark Yarchoan, M.D., chief medical oncology fellow. Work by Dung Le, M.D., associate professor of oncology, and other researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Cancer Institute for Cancer Immunotherapy showed that colon cancers that carry a high number of mutations are more likely to respond to checkpoint inhibitors than those that have fewer mutations. However, exactly how big an effect the mutational burden has on outcomes to immune checkpoint inhibitors across many different cancer types was unclear. To investigate this question, Yarchoan and colleagues Alexander Hopkins, Ph.D., research fellow, and Elizabeth Jaffee, M.D., co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care and associate director of the Bloomberg~Kimmel Institute, combed the medical literature for the results of clinical trials using checkpoint inhibitors on various different types of cancer. They combined these findings with data on the mutational burden of thousands of tumor samples from patients with different tumor types.

Analyzing 27 different cancer types for which both pieces of information were available, the researchers found a strong correlation. The higher a cancer type’s mutational burden tends to be, the more likely it is to respond to checkpoint inhibitors. More than half of the differences in how well cancers responded to immune checkpoint inhibitors could be explained by the mutational burden of that cancer. €œThe idea that a tumor type with more mutations might be easier to treat than one with fewer sounds a little counterintuitive. It’s one of those things that doesn’t sound right when you hear it,” says Hopkins.

€œBut with immunotherapy, the more mutations you have, the more chances the immune system has to recognize the tumor.” Although this finding held true for the vast majority of cancer types they studied, there were some outliers in their analysis, says Yarchoan. For example, Merkel cell cancer, a rare and highly aggressive skin cancer, tends to have a moderate number of mutations yet responds extremely well to checkpoint inhibitors. However, he explains, this cancer type is often caused by a levitra, which seems to encourage a strong immune response despite the cancer’s lower mutational burden. In contrast, the most common type of colorectal cancer has moderate mutational burden, yet responds poorly to checkpoint inhibitors for reasons that are still unclear. Yarchoan notes that these findings could help guide clinical trials to test checkpoint inhibitors on cancer types for which these drugs haven’t yet been tried.

Future studies might also focus on finding ways to prompt cancers with low mutational burdens to behave like those with higher mutational burdens so that they will respond better to these therapies. He and his colleagues plan to extend this line of research by investigating whether mutational burden might be a good predictor of whether cancers in individual patients might respond well to this class of immunotherapy drugs. €œThe end goal is precision medicine—moving beyond what’s true for big groups of patients to see whether we can use this information to help any given patient,” he says. Yarchoan receives funding from the Norman &. Ruth Rales Foundation and the Conquer Cancer Foundation.

Through a licensing agreement with Aduro Biotech, Jaffee has the potential to receive royalties in the future..

Who can buy levitra

En español Latinas are now who can buy levitra the largest group of women workers in the U.S., behind non-Hispanic whites http://performanceandpolitics.aber.ac.uk/event/ppi-distinguished-speaker-event-9/. Numbering more than 12 million, Latinas account for 16% of the female labor force – a figure that is projected to grow dramatically, according to the Bureau of Labor Statistics. While Latinas play a critical role in America’s workforce, their wages continue to lag significantly behind those of who can buy levitra their white male counterparts. This year, Oct.

21 marks Latina Women’s Equal Pay Day, a symbolic representation of the number of additional days Latina women employed full-time, year-round must work, on average, to earn what white, non-Hispanic men earned the year before. Here are who can buy levitra five facts about Latina women in the labor force. 1. Hispanic women experience the largest wage gap of any major racial or ethnic group For every dollar earned by a non-Hispanic white man, a Latina earns just 57 cents – a situation no doubt reflected in the fact that almost 1 in 10 (9%) Latinas working 27 hours or more a week are living below the poverty line.

2 who can buy levitra. Today’s gap reflects a long-standing pattern Looking back over the past 30 years, Latinas have consistently earned less than 60 cents for every dollar earned by non-Hispanic white men. And today’s gap is only about five cents smaller than it was in 1990. African American women, too, have experienced a five-cent narrowing in who can buy levitra the wage gap over that time period.

The wage gap has narrowed by more than 10 cents for white women over the past three decades, and for Asian women the gap has closed. 3. The Latina wage gap persists even after controlling for educational differences Latinas are less likely to have completed education beyond high school than other groups, but who can buy levitra this fact does not explain away the entire wage gap. Even within each educational level, their wages remain relatively low compared with white men.

For instance, among those with a bachelor’s degree, Hispanic women only make 64.6% of what white, non-Hispanic men make. In fact, Hispanic women with bachelor’s degrees have median weekly earnings less than those of white who can buy levitra men with some college or an associate degree. 4. The levitra hit Hispanic women particularly hard Hispanic women experienced the steepest initial employment losses of any major group early in the levitra.

In April 2020, almost one-quarter (23%) fewer Hispanic who can buy levitra women were working relative to just before the levitra in February 2020. In comparison, this figure was 19% for Asian women, 18% for Black women and 16% for non-Hispanic white women. While employment has recovered significantly for other groups since that time, it continues to lag for Hispanic women and Black women who are still experiencing relatively large employment losses (5.2% and 4.7%, respectively). 5 who can buy levitra.

Latinas have relatively high labor force participation rates, and unemployment rates In September 2021, labor force participation for adult Hispanic women was 57.7% and unemployment was 5.6%. In comparison, these figures for adult white women were 56.1% and 3.7%. Explore more data on women in who can buy levitra the workforce and learn more about equity in wages. Eleanor Delamater is a presidential management fellow and Gretchen Livingston is a survey statistician for the U.S.

Department of Labor’s Women’s Bureau. Follow the bureau who can buy levitra on Twitter. @WB_DOL. 5 Datos sobre Latinas en la Fuerza Laboral Por Eleanor Delamater who can buy levitra y Gretchen Livingston Las latinas son ahora el grupo más grande de trabajadoras en los Estados Unidos por detrás de las blancas no hispanas.

Con más de 12 millones, las latinas representan el 16% de la fuerza laboral femenina, una cifra que según la Oficina de Estadísticas Laborales se proyecta crecerá dramáticamente. Si bien las latinas desempeñan un papel fundamental en la fuerza laboral de Estados Unidos, sus salarios continúan a la zaga de los de sus homólogos blancos. El 21 who can buy levitra de octubre de este año marca el Día de Igualdad Salarial de las Mujeres Latinas. La fecha representa simbólicamente la cantidad de días adicionales que las mujeres latinas empleadas a tiempo completo durante todo el año deben trabajar como promedio para llegar a alcanzar a ganar lo que los hombres blancos no hispanos ganaron el año pasado.

A continuación, cinco datos sobre las mujeres latinas en la fuerza laboral. 1. Las mujeres hispanas sufren la brecha salarial más grande de cualquier gran grupo racial o étnico Por cada dólar que gana un hombre blanco no hispano, una latina gana sólo 57 centavos, una situación sin duda reflejada en el hecho de que casi 1 de cada 10 (9%) latinas que trabajan 27 horas o más a la semana viven por debajo del umbral de pobreza. 2.

La brecha actual refleja un patrón de larga data Durante los últimos 30 años, las latinas han estado ganando menos de 60 centavos por cada dólar ganado por hombres blancos no hispanos. Y la brecha actual es sólo cinco centavos más pequeña que en 1990. Las mujeres afroamericanas también han experimentado una reducción de cinco centavos en la brecha salarial durante ese período. La brecha salarial se ha reducido en más de 10 centavos para las mujeres blancas durante las últimas tres décadas, y para las mujeres asiáticas la brecha se ha cerrado.

3. La brecha salarial de las latinas persiste incluso después de considerar las diferencias educativas Es menos probable que en otros grupos que las latinas hayan completado educación más allá de la escuela secundaria, pero este hecho no explica totalmente la brecha salarial. Incluso dentro de cada nivel educativo, sus salarios siguen siendo relativamente bajos en comparación con los de los hombres blancos. Por ejemplo, entre quienes tienen una licenciatura universitaria, las mujeres hispanas sólo reciben el 64,6% de lo que ganan los hombres blancos no hispanos.

De hecho, las mujeres hispanas con títulos universitarios tienen ingresos semanales medios menores que los de los hombres blancos con algún título universitario o asociado. 4. La pandemia ha afectado especialmente a las mujeres hispanas Al comienzo de la pandemia las mujeres hispanas experimentaron inicialmente las pérdidas de empleo más pronunciadas de entre cualquier grupo. En abril de 2020, casi una cuarta parte (23%) menos de mujeres hispanas estaban trabajando en comparación con las cifras de febrero de 2020, justo antes de la pandemia.

Por contra, esta cifra era del 19% de mujeres asiáticas, el 18% de mujeres negras y el 16% de mujeres blancas hispanas. Si bien se ha recuperado significativamente para otros grupos desde entonces, el empleo continúa rezagado para las mujeres hispanas y negras, quienes todavía están experimentando pérdidas laborales relativamente grandes (5.2% y 4.7%, respectivamente). 5. Las latinas tienen tasas de participación en la fuerza laboral y tasas de desempleo relativamente altas En septiembre de 2021, la participación en la fuerza laboral de las mujeres hispanas adultas era del 57,7% y el desempleo era del 5,6%.

Por el contrario, estas cifras para las mujeres blancas adultas fueron del 56,1% y del 3,7%. Eleanor Delamater es becaria presidencial de gestión y Gretchen Livingston es profesional de valoración de estadísticas de encuestas para la Oficina de las Mujeres del Departamento de Trabajo de EE.UU. Siga la oficina por Twitter. @WB_DOL.Emily Lambert is an early childhood educator/caregiver at the On Purpose Academy Mentoring and Learning Center, a childcare facility in Dayton, Ohio.

In August, Secretary Marty Walsh visited this daycare facility for a roundtable about the care economy and the need to invest in caregivers. We asked Emily to share her experience as a caregiver and her perspective on what investments are needed to support caregivers. What led you to a career in early childhood education?. During my freshman year at the University of Dayton, I was very unsure of the career path I wanted to take.

Through a unique club on campus, I was able to become a tutor and work with students from a local school district on their reading. I loved that experience so much and it sparked my passion for teaching. I knew I wanted to be a teacher and I felt the best fit for me was to pursue a career in early childhood education. What do you enjoy most about being an early childhood educator?.

I enjoy teaching students every day, especially when they are in the stages of early childhood. Watching them learn new things and form new connections with the world around them is truly amazing. I love that I have the opportunity to lay the foundation of learning for students and set them up for success in the primary grades. My job as an early childhood educator is critical for a child to progress in their learning so they will be successful in life.

How would you describe care work to someone who isn’t familiar with what you do?. I would describe care work as a very selfless field. In this line of work you are constantly giving to other people to meet their needs. In the line of early childhood education, being selfless looks like putting another person's needs before your own.

In the classroom that can look like maintaining patience, and blocking out your problems as you walk through the door of the classroom to make sure you give the best you can to students. What are some barriers or issues you’ve faced as a caregiver?. After getting my degree in early childhood education, I originally thought I wanted to work in a school district. But after reflecting on it, I felt called to work in an urban center.

A barrier to working in a center is not being seen by the community as a “teacher.”. We are tasked with creating and implementing lesson plans, collecting data and assessments on students just like teachers in a school district do. However because our students are younger, people tend to view us as babysitters, which we are not. Another barrier in this career is the pay and benefits.

First-year teachers in a school district make $35,000-40,000, whereas teachers in centers are lucky to make half of that. While I love what I do, I barely make enough to provide for myself and we are not provided with health insurance options and paid maternity leave like teachers in a school district. Teachers in a preschool center like me are tasked with the same job requirements as a teacher in a school district, so there should not be a disparity in pay and benefits. How would the Build Back Better agenda’s investment in child care support caregivers like you?.

I think that investing in this agenda would support caregivers like me because it would help provide the compensation and benefits that caregivers deserve, and help shift how people perceive daycare centers like mine. I think that it would also allow for more professional development opportunities, which in turn allow teachers in centers to provide a higher quality of education that these students deserve..

En español Latinas are now the largest group levitra for sale near me of women workers in the U.S., behind non-Hispanic whites. Numbering more than 12 million, Latinas account for 16% of the female labor force – a figure that is projected to grow dramatically, according to the Bureau of Labor Statistics. While Latinas play a critical role in America’s workforce, their wages continue levitra for sale near me to lag significantly behind those of their white male counterparts.

This year, Oct. 21 marks Latina Women’s Equal Pay Day, a symbolic representation of the number of additional days Latina women employed full-time, year-round must work, on average, to earn what white, non-Hispanic men earned the year before. Here are five facts about Latina women levitra for sale near me in the labor force.

1. Hispanic women experience the largest wage gap of any major racial or ethnic group For every dollar earned by a non-Hispanic white man, a Latina earns just 57 cents – a situation no doubt reflected in the fact that almost 1 in 10 (9%) Latinas working 27 hours or more a week are living below the poverty line. 2 levitra for sale near me.

Today’s gap reflects a long-standing pattern Looking back over the past 30 years, Latinas have consistently earned less than 60 cents for every dollar earned by non-Hispanic white men. And today’s gap is only about five cents smaller than it was in 1990. African American women, too, have experienced a five-cent narrowing levitra for sale near me in the wage gap over that time period.

The wage gap has narrowed by more than 10 cents for white women over the past three decades, and for Asian women the gap has closed. 3. The Latina wage gap persists even after controlling for educational differences Latinas are less likely to have completed education beyond high school than other levitra for sale near me groups, but this fact does not explain away the entire wage gap.

Even within each educational level, their wages remain relatively low compared with white men. For instance, among those with a bachelor’s degree, Hispanic women only make 64.6% of what white, non-Hispanic men make. In fact, Hispanic women with bachelor’s degrees have median weekly levitra for sale near me earnings less than those of white men with some college or an associate degree.

4. The levitra hit Hispanic women particularly hard Hispanic women experienced the steepest initial employment losses of any major group early in the levitra. In April 2020, almost one-quarter (23%) fewer Hispanic women were working relative to just levitra for sale near me before the levitra in February 2020.

In comparison, this figure was 19% for Asian women, 18% for Black women and 16% for non-Hispanic white women. While employment has recovered significantly for other groups since that time, it continues to lag for Hispanic women and Black women who are still experiencing relatively large employment losses (5.2% and 4.7%, respectively). 5 levitra for sale near me.

Latinas have relatively high labor force participation rates, and unemployment rates In September 2021, labor force participation for adult Hispanic women was 57.7% and unemployment was 5.6%. In comparison, these figures for adult white women were 56.1% and 3.7%. Explore more data on women in the workforce and learn more about equity levitra for sale near me in wages.

Eleanor Delamater is a presidential management fellow and Gretchen Livingston is a survey statistician for the U.S. Department of Labor’s Women’s Bureau. Follow the bureau on levitra for sale near me Twitter.

@WB_DOL. 5 Datos sobre Latinas en la Fuerza Laboral Por Eleanor Delamater y Gretchen Livingston Las latinas son ahora el grupo levitra for sale near me más grande de trabajadoras en los Estados Unidos por detrás de las blancas no hispanas. Con más de 12 millones, las latinas representan el 16% de la fuerza laboral femenina, una cifra que según la Oficina de Estadísticas Laborales se proyecta crecerá dramáticamente.

Si bien las latinas desempeñan un papel fundamental en la fuerza laboral de Estados Unidos, sus salarios continúan a la zaga de los de sus homólogos blancos. El 21 de levitra for sale near me octubre de este año marca el Día de Igualdad Salarial de las Mujeres Latinas. La fecha representa simbólicamente la cantidad de días adicionales que las mujeres latinas empleadas a tiempo completo durante todo el año deben trabajar como promedio para llegar a alcanzar a ganar lo que los hombres blancos no hispanos ganaron el año pasado.

A continuación, cinco datos sobre las mujeres latinas en la fuerza laboral. 1. Las mujeres hispanas sufren la brecha salarial más grande de cualquier gran grupo racial o étnico Por cada dólar que gana un hombre blanco no hispano, una latina gana sólo 57 centavos, una situación sin duda reflejada en el hecho de que casi 1 de cada 10 (9%) latinas que trabajan 27 horas o más a la semana viven por debajo del umbral de pobreza.

2. La brecha actual refleja un patrón de larga data Durante los últimos 30 años, las latinas han estado ganando menos de 60 centavos por cada dólar ganado por hombres blancos no hispanos. Y la brecha actual es sólo cinco centavos más pequeña que en 1990.

Las mujeres afroamericanas también han experimentado una reducción de cinco centavos en la brecha salarial durante ese período. La brecha salarial se ha reducido en más de 10 centavos para las mujeres blancas durante las últimas tres décadas, y para las mujeres asiáticas la brecha se ha cerrado. 3.

La brecha salarial de las latinas persiste incluso después de considerar las diferencias educativas Es menos probable que en otros grupos que las latinas hayan completado educación más allá de la escuela secundaria, pero este hecho no explica totalmente la brecha salarial. Incluso dentro de cada nivel educativo, sus salarios siguen siendo relativamente bajos en comparación con los de los hombres blancos. Por ejemplo, entre quienes tienen una licenciatura universitaria, las mujeres hispanas sólo reciben el 64,6% de lo que ganan los hombres blancos no hispanos.

De hecho, las mujeres hispanas con títulos universitarios tienen ingresos semanales medios menores que los de los hombres blancos con algún título universitario o asociado. 4. La pandemia ha afectado especialmente a las mujeres hispanas Al comienzo de la pandemia las mujeres hispanas experimentaron inicialmente las pérdidas de empleo más pronunciadas de entre cualquier grupo.

En abril de 2020, casi una cuarta parte (23%) menos de mujeres hispanas estaban trabajando en comparación con las cifras de febrero de 2020, justo antes de la pandemia. Por contra, esta cifra era del 19% de mujeres asiáticas, el 18% de mujeres negras y el 16% de mujeres blancas hispanas. Si bien se ha recuperado significativamente para otros grupos desde entonces, el empleo continúa rezagado para las mujeres hispanas y negras, quienes todavía están experimentando pérdidas laborales relativamente grandes (5.2% y 4.7%, respectivamente).

5. Las latinas tienen tasas de participación en la fuerza laboral y tasas de desempleo relativamente altas En septiembre de 2021, la participación en la fuerza laboral de las mujeres hispanas adultas era del 57,7% y el desempleo era del 5,6%. Por el contrario, estas cifras para las mujeres blancas adultas fueron del 56,1% y del 3,7%.

Eleanor Delamater es becaria presidencial de gestión y Gretchen Livingston es profesional de valoración de estadísticas de encuestas para la Oficina de las Mujeres del Departamento de Trabajo de EE.UU. Siga la oficina por Twitter. @WB_DOL.Emily Lambert is an early childhood educator/caregiver at the On Purpose Academy Mentoring and Learning Center, a childcare facility in Dayton, Ohio.

In August, Secretary Marty Walsh visited this daycare facility for a roundtable about the care economy and the need to invest in caregivers. We asked Emily to share her experience as a caregiver and her perspective on what investments are needed to support caregivers. What led you to a career in early childhood education?.

During my freshman year at the University of Dayton, I was very unsure of the career path I wanted to take. Through a unique club on campus, I was able to become a tutor and work with students from a local school district on their reading. I loved that experience so much and it sparked my passion for teaching.

I knew I wanted to be a teacher and I felt the best fit for me was to pursue a career in early childhood education. What do you enjoy most about being an early childhood educator?. I enjoy teaching students every day, especially when they are in the stages of early childhood.

Watching them learn new things and form new connections with the world around them is truly amazing. I love that I have the opportunity to lay the foundation of learning for students and set them up for success in the primary grades. My job as an early childhood educator is critical for a child to progress in their learning so they will be successful in life.

How would you describe care work to someone who isn’t familiar with what you do?. I would describe care work as a very selfless field. In this line of work you are constantly giving to other people to meet their needs.

In the line of early childhood education, being selfless looks like putting another person's needs before your own. In the classroom that can look like maintaining patience, and blocking out your problems as you walk through the door of the classroom to make sure you give the best you can to students. What are some barriers or issues you’ve faced as a caregiver?.

After getting my degree in early childhood education, I originally thought I wanted to work in a school district. But after reflecting on it, I felt called to work in an urban center. A barrier to working in a center is not being seen by the community as a “teacher.”.

We are tasked with creating and implementing lesson plans, collecting data and assessments on students just like teachers in a school district do. However because our students are younger, people tend to view us as babysitters, which we are not. Another barrier in this career is the pay and benefits.

First-year teachers in a school district make $35,000-40,000, whereas teachers in centers are lucky to make half of that. While I love what I do, I barely make enough to provide for myself and we are not provided with health insurance options and paid maternity leave like teachers in a school district. Teachers in a preschool center like me are tasked with the same job requirements as a teacher in a school district, so there should not be a disparity in pay and benefits.

How would the Build Back Better agenda’s investment in child care support caregivers like you?. I think that investing in this agenda would support caregivers like me because it would help provide the compensation and benefits that caregivers deserve, and help shift how people perceive daycare centers like mine. I think that it would also allow for more professional development opportunities, which in turn allow teachers in centers to provide a higher quality of education that these students deserve..

Generic levitra 40mg

Medanta taps Qure.ai for AI-driven chest x-ray analysisMedanta, a multi-speciality medical group in India, http://www.em-hay-reichstett.site.ac-strasbourg.fr/?page_id=1367 has generic levitra 40mg partnered with Qure.ai to implement the latter's artificial intelligence software to enhance chest x-ray analysis. The hospital group will be adopting the qXR software which automatically analyses chest x-rays and spots generic levitra 40mg findings for better diagnosis and treatment. The AI tool can detect 30 abnormalities of the lungs, pleura, heart, bones and diaphragm. "Medanta strives generic levitra 40mg to deliver world-class healthcare through its high-end medical equipment and superior infrastructure. State-of-the-art technology is an essential aspect of healthcare delivery," Dr Naresh Trehan, chairman and managing director of Medanta, was quoted as saying in a news report.

The Qure.ai software has also been adopted by Fujifilm Corporation for its portable X-ray FDR Xair system generic levitra 40mg. Through its recent partnership with AstraZeneca Malaysia, the startup has brought its x-ray software to some primary care clinics in Malaysia to support the early detection of lung cancer there.Medical cobotics centre to be launched in IndiaThe I-Hub Foundation for Cobotics at the Indian Institute of Technology – Delhi (IIT Delhi) and iHub Anubhuti at the Indraprastha Institute of Information Technology – Delhi (IIITD) have signed a memorandum of understanding to set up India's first medical cobotics centre.The two government-backed university technology hubs have been developing advanced technologies in robotics and collaborative robots (cobotics), digital health, sensing and computing technologies for robotic-assisted surgeries, training, and medical procedures.According to a press statement, the Medical Cobotics Centre (MCC) at IIITD will be a tech-enabled medical simulation and training facility for young resident doctors, as well as other healthcare professionals, paramedical staff, technicians, engineers, and researchers. It will also serve as a validation centre for research outcomes in the area of generic levitra 40mg healthcare cobotics and digital health. This upcoming facility will establish partnerships with companies, undertake research, and work toward the commercialisation of technologies.MMC's training programmes will be at multiple levels and cohort-specific, such as urology, neurology, and laparoscopy, but will be initially limited to minimally invasive generic levitra 40mg surgeries. Experts from All India Institute of Medical Sciences in New Delhi and other medical colleges will be consulted for these programmes and invited as guest faculty to conduct them.The first batch of trainees is targeted to be inducted around April-May next year.

They will be initially trained with basic training simulators while advanced surgical robots will come in the next generic levitra 40mg phase. Moreover, the centre will also be a place for various technology innovation hubs under the Indian government's National Mission on Interdisciplinary Cyber-Physical Systems to "showcase their medical-related projects and products with applications," according to IHFC CEO Ashutosh Dutt Sharm and IHFC Project Director Subir Kumar Saha.Philips Foundation backs cardiac rehab programme in SingaporePhilips Foundation is funding one of the centres run by social service agency Singapore Heart Foundation that provides subsidised cardiac rehabilitation services. The year-long project of Royal Philips' non-profit organisation aims generic levitra 40mg to reduce the mortality rate of cardiac incidences and help lower a patient's risk of hospital readmission. Specifically, it intends to close the gap in patients' lack of participation in rehab programmes, which is considered a huge barrier in the secondary prevention of heart diseases. It was reported that only generic levitra 40mg between 6%-15% of Singaporean patients attend cardiac rehabilitation programmes.

SHF–Philips Foundation Heart Wellness Centre is one of the social services' three centres that provide cardiac patients and at-risk individuals with access to heart health.Philips' support, according to SHF Heart Wellness Centres Chairman Dr Tan Yong Seng, will provide SHF with the "resources required to continue providing affordable and quality support to the patients in need, as well as give our team the capacity to focus on raising awareness on the importance of cardiac rehab[ilitation] and drive higher participation in our programmes".Under the partnership, 20 sites in Singapore will be equipped with the Philips HeartStart automated external defibrillators (AED) and 500 persons will be trained in giving cardiopulmonary resuscitation (CPR) and AED over a year."Through the heart wellness centre's education initiatives, the AED roll-out and the CPR training, we want to equip individuals and communities with the knowledge and resources to reduce the mortality rates of cardiac incidences in Singapore," Philips Singapore Country Manager Ivy Lai said.A team of French cognitive scientists has addressed the urgent issue of treatment hesitancy within many EU countries and proposes a new approach. With a study published generic levitra 40mg in October this year, the researchers successfully demonstrated that the reluctance to be vaccinated could be decreased by deploying chatbot technology.WHY IT MATTERSThe chatbot study involved researchers from the Centre National de la Recherche Scientifique (CNRS), the French National Institute of Health and Medical Research INSERM and ENS-PSL.The study, published in the Journal of Experimental Psychology. Applied, found that interaction with a chatbot developed by CNRS, ENS-PSL and INSERM was able to reduce vaccination refusal by 20 per cent within a test group of 338 participants.In the control group, which received only brief information about the erectile dysfunction treatment vaccination, there were no comparable results in terms of general views and willingness to vaccinate.THE LARGER TRENDAlthough nearly three-quarters of all adult Europeans are now fully vaccinated against erectile dysfunction treatment, there remain huge disparities in vaccination rates across countries.According to the treatment tracker of the European Centre for Disease Prevention and Control (ECDC) as of 25 November 2021, individual EU countries such as Portugal (81.5 generic levitra 40mg per cent), Ireland (76.2 per cent) and Denmark (76 per cent) have already made great progress in immunising their populations with a full erectile dysfunction treatment vaccination, while the vaccination rate of other countries such as Germany, France or Austria continues to stagnate at below 70 per cent.In other parts of Europe, especially in the south-west, the vaccination rates are significantly lower than 50 per cent. In Slovakia (45.7 per cent), Romania (37.3 per cent) and Bulgaria (24.7 per cent), very few people have received the double erectile dysfunction treatment dose.These vaccination backlogs are not only due to treatment shortages, but in many cases a result of existing scepticism of many Europeans.The researchers from France now hope that technology-based communication, such as chatbots, could have a positive impact on these figures in the future.ON THE RECORD“It remains to be shown whether the effects of chatbot interaction are lasting, and whether they are the same across age groups, and among those most resistant to vaccination”, emphasised the authors of the study with predominantly young and well-educated participants.They added. €œHalf of the experimental group later tried to persuade others to get vaccinated, with generic levitra 40mg three-quarters of them stating they drew information provided by the chatbot to do so.”The government-backed Digital Health Cooperative Research Centre has launched a A$1 million (above $700,000) research project that intends to empower accurate prescription of medications for patients dealing with kidney failure.WHAT IT'S ABOUTThe research institute, in tandem with the Northern Territory Health and the University of South Australia, will develop this clinical decision support tool for healthcare professionals that will be delivered as a standalone service via an application program interface, making it easy to integrate with existing prescribing or dispensing software systems.After analysing the context of medicine prescription and dispensing in the first research phase, they will create a renal dosage calculator algorithm based on NT Health's clinical data sets and other available medicine knowledge databases.

In the second phase, they will simulate the impact of the tool in the urban and rural primacy clinics in NT and South Australia. The final generic levitra 40mg research phase involves a clinical pilot in NT's urban and remote primary health care centres and community pharmacy settings. WHY IT MATTERSInaccurate medicine selection and dosing for people with impaired kidneys is a "common and preventable issue," according to the UniSA research team. They noted that about a quarter of patients receive "inappropriate" medications, which in turn contribute to up to a tenth of adverse reactions that could lead to hospital admissions."A digital solution targeting this problem has the potential to prevent 25,000 medication-related admissions annually," said Libby Roughead, a professor at UniSA who also leads generic levitra 40mg the university's research team. Moreover, medication-related problems account for over 250,000 yearly hospital admissions, costing A$1.4 billion ($1 billion) each year, noted Dr Terry Sweeney, CEO of DHCRC.About 700,000 Australians over the age of 65 with renal function problems, as well as Aboriginal and Torres Strait Islander peoples, are generic levitra 40mg targeted beneficiaries of the project, according to the DHCRC.

It was mentioned that seven in 10 hospitalisations from chronic kidney disease occur among senior Australians while one in five indigenous Australians has shown signs of the disease.The research project, said Bhavini Patel, executive director of Medicines Management at NT Health, will "ensure safer prescribing and dispensing of medications for people living with kidney disease and reduce the risk of medication associated renal problems".THE LARGER TRENDLast month, the DHCRC set up a $2.1 million research project that will improve clinical decision support tools across regional and metropolitan hospitals settings in the country. The three-year project aims to enhance the fit between decision support technologies and their users generic levitra 40mg. To achieve this, it will make use of Alcidion's Miya Precision system to point out priority areas where decision support tools will add value. In September, the research firm also launched a project, together with UniSA and SA Health, to create a digital analytics tool that predicts the risk of adverse events generic levitra 40mg in hospitals. It was said that the tool will be used to develop a visual programme that will provide clinicians and administrators with real-time insights describing a hospital's risk exposure.

The project ultimately intends to resolve patient safety issues, generic levitra 40mg such as ramping, suicide prevention, medication and falls incidents.The U.S. Cybersecurity and Infrastructure Security Agency and the Federal Bureau of Investigation issued a reminder this week to critical infrastructure partners that bad actors are unlikely to take a break for the holiday season. Although neither generic levitra 40mg CISA nor FBI have identified specific threats looming, they noted that previous incidents over U.S. Holidays have generic levitra 40mg set a concerning precedent. "Recent history tells us that this could be a time when these persistent cyber actors halfway across the world are looking for ways – big and small – to disrupt the critical networks and systems belonging to organizations, businesses and critical infrastructure," said the agencies in a joint bulletin.

WHY IT MATTERS As CISA and the FBI pointed out, holidays such as Thanksgiving often mean offices are closed, and security professionals may be less generic levitra 40mg attentive. Still, they said, organizations can take several actions cheapest levitra uk to try and proactively protect against cyberattacks. They recommended that all entities, especially critical infrastructure partners, to implement best practices, generic levitra 40mg including. Identifying IT security employees for weekends and holidays who would be available to surge during these times in the event of an incident Implementing multi-factor authentication for remote access and administrative accounts Mandating strong passwords and ensuring they are not reused across multiple accountsEnsuring remote desktop protocol is secure and monitoredReminding employees not to click on suspicious links, and conducting exercises to raise awareness The agencies also urged organizations to stay vigilant against known cybercrime techniques, such as phishing scams, fraudulent sites spoofing reputable businesses and unencrypted financial transactions. "Finally generic levitra 40mg – to reduce the risk of severe business/functional degradation should your organization fall victim to a ransomware attack – review and, if needed, update your incident response and communication plans," said the agencies, directing organizations to ransomware awareness resources regarding holidays and weekends.

"These plans should list actions to take – and contacts to reach out to generic levitra 40mg – should your organization be impacted by a ransomware incident." THE LARGER TRENDThis isn't the first time CISA and the FBI have issued a holiday ransomware warning. Before Labor Day weekend, the agencies raised similar concerns, pointing to attacks on critical infrastructure on Mother's Day, Memorial Day and Independence Day. It also seems, however, that generic levitra 40mg hackers need no special occasion to cause a ruckus. This year has seen a rise in cyber attacks and data breaches in the healthcare sector, with more than 40 million patient records compromised by incidents reported to the federal government in 2021. ON THE RECORD "As Americans prepare to hit the highways and airports this Thanksgiving holiday, CISA and the FBI are reminding critical infrastructure partners that malicious cyber actors aren’t making the same holiday plans as you," said the agencies in generic levitra 40mg the bulletin.

Kat Jercich is senior editor of Healthcare IT News.Twitter. @kjercichEmail. Kjercich@himss.orgHealthcare IT News is a HIMSS Media publication.Apple announced this week that it was suing NSO Group, an Israeli surveillance technology company, in federal court for allegedly accessing users' devices without authorization. In addition to damages, the tech giant is seeking to block NSO Group from accessing or using any Apple products, or developing spyware that could be used on Apple products in the future. "State-sponsored actors like the NSO Group spend millions of dollars on sophisticated surveillance technologies without effective accountability," said Craig Federighi, Apple’s senior vice president of software engineering, in a statement.

"That needs to change." Apple devices are "the most secure consumer hardware on the market," he contended, but "private companies developing state-sponsored spyware have become even more dangerous. "While these cybersecurity threats only impact a very small number of our customers, we take any attack on our users very seriously, and we’re constantly working to strengthen the security and privacy protections in iOS to keep all our users safe," Federighi added. NSO Group offered a statement to Healthcare IT News in response to requests for comment. "Thousands of lives were saved around the world thanks to NSO Group's technologies used by its customers," said NSO Group representatives. "Pedophiles and terrorists can freely operate in technological safe-havens, and we provide governments the lawful tools to fight it.

NSO Group will continue to advocate for the truth." WHY IT MATTERS NSO Group says its surveillance technology is used by government intelligence and law enforcement agencies to track criminals. But as Apple outlines in its complaint, the company's spyware has reportedly been used against journalists, human rights activists, dissidents, public officials and others.This month, the U.S. Department of Commerce included the NSO Group in its Entity List for "engaging in activities that are contrary to the national security or foreign policy interests of the United States." Specifically, the agency said that NSO Group had enabled foreign governments, via its spyware, to "maliciously target" individuals such as embassy workers and academics and to "conduct transnational repression." In its complaint, Apple zeroed in on "FORCEDENTRY," an exploit for a vulnerability used to break into a victim's device and install NSO Group's Pegasus spyware product. The company accused attackers of creating Apple IDs to send malicious data to a victim's device, which then allowed NSO Group or its clients to surreptitiously deliver Pegasus. "On information and belief, Defendants provide consulting and expert services to their clients, assist them with their deployment and use of Pegasus, and participate in their attacks on Apple devices, servers and users," according to the complaint.

Although Apple has not observed any evidence of successful remote attacks against devices running iOS 15 or later, it said that each attack carries substantial costs for the company, including the necessity to redirect resources. "In the meantime, on information and belief, Defendants continue with their pernicious efforts to target and harm Apple and its customers by infecting, exploiting, and misusing Apple devices and software," said the complaint. The company also announced that it would be contributing any damages from the lawsuit, plus an extra $10 million, to organizations pursuing cybersurveillance research and advocacy. "At Apple, we are always working to defend our users against even the most complex cyberattacks," said Ivan Krstić, head of Apple Security Engineering and Architecture, in a statement. "The steps we’re taking today will send a clear message.

In a free society, it is unacceptable to weaponize powerful state-sponsored spyware against those who seek to make the world a better place." THE LARGER TRENDNation-states have increasingly relied on sophisticated software to carry out governmental objectives. As Errol Weiss, H-ISAC chief security officer, pointed out in an interview with Healthcare IT News earlier this month, cyber-offensive capabilities have now become the norm, not the exception."A few years ago, you could count maybe a few dozen countries that had a decent, offensive cyber capability. And now it's probably the opposite," he said. The U.S. Government has raised the alarm about these developments, most recently regarding an Iran-sponsored hacker group targeting healthcare.ON THE RECORD "Our threat intelligence and engineering teams work around the clock to analyze new threats, rapidly patch vulnerabilities, and develop industry-leading new protections in our software and silicon," said Apple's Krstić in a statement."Apple runs one of the most sophisticated security engineering operations in the world, and we will continue to work tirelessly to protect our users from abusive state-sponsored actors like NSO Group," he said.

Kat Jercich is senior editor of Healthcare IT News.Twitter. @kjercichEmail. Kjercich@himss.orgHealthcare IT News is a HIMSS Media publication..

Medanta taps Qure.ai for AI-driven chest http://www.svb-burgdorf.de/portfolio-item/chair-2/ x-ray analysisMedanta, a multi-speciality medical group in India, has partnered with Qure.ai to implement the latter's artificial intelligence software to enhance chest x-ray levitra for sale near me analysis. The hospital group will be adopting the qXR software which automatically analyses levitra for sale near me chest x-rays and spots findings for better diagnosis and treatment. The AI tool can detect 30 abnormalities of the lungs, pleura, heart, bones and diaphragm. "Medanta strives to deliver world-class levitra for sale near me healthcare through its high-end medical equipment and superior infrastructure.

State-of-the-art technology is an essential aspect of healthcare delivery," Dr Naresh Trehan, chairman and managing director of Medanta, was quoted as saying in a news report. The Qure.ai software has also been adopted by Fujifilm Corporation for its portable X-ray FDR Xair system levitra for sale near me. Through its recent partnership with AstraZeneca Malaysia, the startup has brought its x-ray software to some primary care clinics in Malaysia to support the early detection of lung cancer there.Medical cobotics centre to be launched in IndiaThe I-Hub Foundation for Cobotics at the Indian Institute of Technology – Delhi (IIT Delhi) and iHub Anubhuti at the Indraprastha Institute of Information Technology – Delhi (IIITD) have signed a memorandum of understanding to set up India's first medical cobotics centre.The two government-backed university technology hubs have been developing advanced technologies in robotics and collaborative robots (cobotics), digital health, sensing and computing technologies for robotic-assisted surgeries, training, and medical procedures.According to a press statement, the Medical Cobotics Centre (MCC) at IIITD will be a tech-enabled medical simulation and training facility for young resident doctors, as well as other healthcare professionals, paramedical staff, technicians, engineers, and researchers. It will also serve as a validation centre for research levitra for sale near me outcomes in the area of healthcare cobotics and digital health.

This upcoming facility will establish partnerships with companies, undertake research, and work toward the commercialisation of technologies.MMC's training programmes will be at multiple levels and cohort-specific, such as urology, neurology, and laparoscopy, but will be initially limited to minimally levitra for sale near me invasive surgeries. Experts from All India Institute of Medical Sciences in New Delhi and other medical colleges will be consulted for these programmes and invited as guest faculty to conduct them.The first batch of trainees is targeted to be inducted around April-May next year. They will levitra for sale near me be initially trained with basic training simulators while advanced surgical robots will come in the next phase. Moreover, the centre will also be a place for various technology innovation hubs under the Indian government's National Mission on Interdisciplinary Cyber-Physical Systems to "showcase their medical-related projects and products with applications," according to IHFC CEO Ashutosh Dutt Sharm and IHFC Project Director Subir Kumar Saha.Philips Foundation backs cardiac rehab programme in SingaporePhilips Foundation is funding one of the centres run by social service agency Singapore Heart Foundation that provides subsidised cardiac rehabilitation services.

The year-long project of Royal Philips' non-profit organisation aims to reduce the mortality rate of cardiac incidences and help lower a patient's risk levitra for sale near me of hospital readmission. Specifically, it intends to close the gap in patients' lack of participation in rehab programmes, which is considered a huge barrier in the secondary prevention of heart diseases. It was reported that only between levitra for sale near me 6%-15% of Singaporean patients attend cardiac rehabilitation programmes. SHF–Philips Foundation Heart Wellness Centre is one of the social services' three centres that provide cardiac patients and at-risk individuals with access to heart health.Philips' support, according to SHF Heart Wellness Centres Chairman Dr Tan Yong Seng, will provide SHF with the "resources required to continue providing affordable and quality support to the patients in need, as well as give our team the capacity to focus on raising awareness on the importance of cardiac rehab[ilitation] and drive higher participation in our programmes".Under the partnership, 20 sites in Singapore will be equipped with the Philips HeartStart automated external defibrillators (AED) and 500 persons will be trained in giving cardiopulmonary resuscitation (CPR) and AED over a year."Through the heart wellness centre's education initiatives, the AED roll-out and the CPR training, we want to equip individuals and communities with the knowledge and resources to reduce the mortality rates of cardiac incidences in Singapore," Philips Singapore Country Manager Ivy Lai said.A team of French cognitive scientists has addressed the urgent issue of treatment hesitancy within many EU countries and proposes a new approach.

With a study published in October this year, the researchers successfully demonstrated that the reluctance to be vaccinated could be decreased by deploying chatbot technology.WHY IT MATTERSThe chatbot study involved researchers levitra for sale near me from the Centre National de la Recherche Scientifique (CNRS), the French National Institute of Health and Medical Research INSERM and ENS-PSL.The study, published in the Journal of Experimental Psychology. Applied, found that interaction with a chatbot developed by CNRS, ENS-PSL and INSERM was able to reduce vaccination refusal by 20 per cent within a test group of 338 participants.In the control group, which received levitra for sale near me only brief information about the erectile dysfunction treatment vaccination, there were no comparable results in terms of general views and willingness to vaccinate.THE LARGER TRENDAlthough nearly three-quarters of all adult Europeans are now fully vaccinated against erectile dysfunction treatment, there remain huge disparities in vaccination rates across countries.According to the treatment tracker of the European Centre for Disease Prevention and Control (ECDC) as of 25 November 2021, individual EU countries such as Portugal (81.5 per cent), Ireland (76.2 per cent) and Denmark (76 per cent) have already made great progress in immunising their populations with a full erectile dysfunction treatment vaccination, while the vaccination rate of other countries such as Germany, France or Austria continues to stagnate at below 70 per cent.In other parts of Europe, especially in the south-west, the vaccination rates are significantly lower than 50 per cent. In Slovakia (45.7 per cent), Romania (37.3 per cent) and Bulgaria (24.7 per cent), very few people have received the double erectile dysfunction treatment dose.These vaccination backlogs are not only due to treatment shortages, but in many cases a result of existing scepticism of many Europeans.The researchers from France now hope that technology-based communication, such as chatbots, could have a positive impact on these figures in the future.ON THE RECORD“It remains to be shown whether the effects of chatbot interaction are lasting, and whether they are the same across age groups, and among those most resistant to vaccination”, emphasised the authors of the study with predominantly young and well-educated participants.They added. €œHalf of the experimental group later tried to persuade others to get vaccinated, with three-quarters of them stating they drew information provided by the chatbot to do so.”The government-backed Digital Health Cooperative Research Centre has launched a A$1 million (above $700,000) research project that intends to empower accurate prescription levitra for sale near me of medications for patients dealing with kidney failure.WHAT IT'S ABOUTThe research institute, in tandem with the Northern Territory Health and the University of South Australia, will develop this clinical decision support tool for healthcare professionals that will be delivered as a standalone service via an application program interface, making it easy to integrate with existing prescribing or dispensing software systems.After analysing the context of medicine prescription and dispensing in the first research phase, they will create a renal dosage calculator algorithm based on NT Health's clinical data sets and other available medicine knowledge databases.

In the second phase, they will simulate the impact of the tool in the urban and rural primacy clinics in NT and South Australia. The final research phase involves a clinical pilot in NT's urban and remote primary health care centres and community levitra for sale near me pharmacy settings. WHY IT MATTERSInaccurate medicine selection and dosing for people with impaired kidneys is a "common and preventable issue," according to the UniSA research team. They noted that about a quarter of patients receive "inappropriate" medications, which in turn contribute to up to a tenth of adverse reactions that could lead to hospital admissions."A digital solution targeting this problem has the potential to prevent 25,000 medication-related admissions annually," said Libby Roughead, levitra for sale near me a professor at UniSA who also leads the university's research team.

Moreover, medication-related problems account for over 250,000 yearly hospital admissions, costing A$1.4 billion ($1 billion) each year, noted Dr Terry Sweeney, CEO of DHCRC.About 700,000 Australians over the age of 65 with renal function problems, as well as Aboriginal and Torres Strait Islander peoples, are targeted beneficiaries of the levitra for sale near me project, according to the DHCRC. It was mentioned that seven in 10 hospitalisations from chronic kidney disease occur among senior Australians while one in five indigenous Australians has shown signs of the disease.The research project, said Bhavini Patel, executive director of Medicines Management at NT Health, will "ensure safer prescribing and dispensing of medications for people living with kidney disease and reduce the risk of medication associated renal problems".THE LARGER TRENDLast month, the DHCRC set up a $2.1 million research project that will improve clinical decision support tools across regional and metropolitan hospitals settings in the country. The three-year project aims to enhance the fit between decision support technologies levitra for sale near me and their users. To achieve this, it will make use of Alcidion's Miya Precision system to point out priority areas where decision support tools will add value.

In September, the research firm also launched a project, together levitra for sale near me with UniSA and SA Health, to create a digital analytics tool that predicts the risk of adverse events in hospitals. It was said that the tool will be used to develop a visual programme that will provide clinicians and administrators with real-time insights describing a hospital's risk exposure. The project ultimately intends levitra for sale near me to resolve patient safety issues, such as ramping, suicide prevention, medication and falls incidents.The U.S. Cybersecurity and Infrastructure Security Agency and the Federal Bureau of Investigation issued a reminder this week to critical infrastructure partners that bad actors are unlikely to take a break for the holiday season.

Although neither CISA nor FBI have levitra for sale near me identified specific threats looming, they noted that previous incidents over U.S. Holidays have set levitra for sale near me a concerning precedent. "Recent history tells us that this could be a time when these persistent cyber actors halfway across the world are looking for ways – big and small – to disrupt the critical networks and systems belonging to organizations, businesses and critical infrastructure," said the agencies in a joint bulletin. WHY IT MATTERS As CISA and the FBI pointed out, holidays such as levitra for sale near me Thanksgiving often mean offices are closed, and security professionals may be less attentive.

Still, they said, organizations can take several actions to try and levitra sale proactively protect against cyberattacks. They recommended that all entities, especially critical infrastructure partners, to implement levitra for sale near me best practices, including. Identifying IT security employees for weekends and holidays who would be available to surge during these times in the event of an incident Implementing multi-factor authentication for remote access and administrative accounts Mandating strong passwords and ensuring they are not reused across multiple accountsEnsuring remote desktop protocol is secure and monitoredReminding employees not to click on suspicious links, and conducting exercises to raise awareness The agencies also urged organizations to stay vigilant against known cybercrime techniques, such as phishing scams, fraudulent sites spoofing reputable businesses and unencrypted financial transactions. "Finally – to reduce the risk of severe business/functional degradation should your organization fall victim to a ransomware attack – review and, if needed, update your incident response and levitra for sale near me communication plans," said the agencies, directing organizations to ransomware awareness resources regarding holidays and weekends.

"These plans should list actions to take – and contacts to reach out to – should your organization be impacted levitra for sale near me by a ransomware incident." THE LARGER TRENDThis isn't the first time CISA and the FBI have issued a holiday ransomware warning. Before Labor Day weekend, the agencies raised similar concerns, pointing to attacks on critical infrastructure on Mother's Day, Memorial Day and Independence Day. It also seems, however, that hackers need no special occasion to cause levitra for sale near me a ruckus. This year has seen a rise in cyber attacks and data breaches in the healthcare sector, with more than 40 million patient records compromised by incidents reported to the federal government in 2021.

ON THE RECORD "As Americans prepare to hit the highways and airports this Thanksgiving levitra for sale near me holiday, CISA and the FBI are reminding critical infrastructure partners that malicious cyber actors aren’t making the same holiday plans as you," said the agencies in the bulletin. Kat Jercich is senior editor of Healthcare IT News.Twitter. @kjercichEmail. Kjercich@himss.orgHealthcare IT News is a HIMSS Media publication.Apple announced this week that it was suing NSO Group, an Israeli surveillance technology company, in federal court for allegedly accessing users' devices without authorization.

In addition to damages, the tech giant is seeking to block NSO Group from accessing or using any Apple products, or developing spyware that could be used on Apple products in the future. "State-sponsored actors like the NSO Group spend millions of dollars on sophisticated surveillance technologies without effective accountability," said Craig Federighi, Apple’s senior vice president of software engineering, in a statement. "That needs to change." Apple devices are "the most secure consumer hardware on the market," he contended, but "private companies developing state-sponsored spyware have become even more dangerous. "While these cybersecurity threats only impact a very small number of our customers, we take any attack on our users very seriously, and we’re constantly working to strengthen the security and privacy protections in iOS to keep all our users safe," Federighi added.

NSO Group offered a statement to Healthcare IT News in response to requests for comment. "Thousands of lives were saved around the world thanks to NSO Group's technologies used by its customers," said NSO Group representatives. "Pedophiles and terrorists can freely operate in technological safe-havens, and we provide governments the lawful tools to fight it. NSO Group will continue to advocate for the truth." WHY IT MATTERS NSO Group says its surveillance technology is used by government intelligence and law enforcement agencies to track criminals.

But as Apple outlines in its complaint, the company's spyware has reportedly been used against journalists, human rights activists, dissidents, public officials and others.This month, the U.S. Department of Commerce included the NSO Group in its Entity List for "engaging in activities that are contrary to the national security or foreign policy interests of the United States." Specifically, the agency said that NSO Group had enabled foreign governments, via its spyware, to "maliciously target" individuals such as embassy workers and academics and to "conduct transnational repression." In its complaint, Apple zeroed in on "FORCEDENTRY," an exploit for a vulnerability used to break into a victim's device and install NSO Group's Pegasus spyware product. The company accused attackers of creating Apple IDs to send malicious data to a victim's device, which then allowed NSO Group or its clients to surreptitiously deliver Pegasus. "On information and belief, Defendants provide consulting and expert services to their clients, assist them with their deployment and use of Pegasus, and participate in their attacks on Apple devices, servers and users," according to the complaint.

Although Apple has not observed any evidence of successful remote attacks against devices running iOS 15 or later, it said that each attack carries substantial costs for the company, including the necessity to redirect resources. "In the meantime, on information and belief, Defendants continue with their pernicious efforts to target and harm Apple and its customers by infecting, exploiting, and misusing Apple devices and software," said the complaint. The company also announced that it would be contributing any damages from the lawsuit, plus an extra $10 million, to organizations pursuing cybersurveillance research and advocacy. "At Apple, we are always working to defend our users against even the most complex cyberattacks," said Ivan Krstić, head of Apple Security Engineering and Architecture, in a statement.

"The steps we’re taking today will send a clear message. In a free society, it is unacceptable to weaponize powerful state-sponsored spyware against those who seek to make the world a better place." THE LARGER TRENDNation-states have increasingly relied on sophisticated software to carry out governmental objectives. As Errol Weiss, H-ISAC chief security officer, pointed out in an interview with Healthcare IT News earlier this month, cyber-offensive capabilities have now become the norm, not the exception."A few years ago, you could count maybe a few dozen countries that had a decent, offensive cyber capability. And now it's probably the opposite," he said.

The U.S. Government has raised the alarm about these developments, most recently regarding an Iran-sponsored hacker group targeting healthcare.ON THE RECORD "Our threat intelligence and engineering teams work around the clock to analyze new threats, rapidly patch vulnerabilities, and develop industry-leading new protections in our software and silicon," said Apple's Krstić in a statement."Apple runs one of the most sophisticated security engineering operations in the world, and we will continue to work tirelessly to protect our users from abusive state-sponsored actors like NSO Group," he said. Kat Jercich is senior editor of Healthcare IT News.Twitter. @kjercichEmail.

Kjercich@himss.orgHealthcare IT News is a HIMSS Media publication..